메뉴 건너뛰기




Volumn , Issue , 2006, Pages 1-280

Surviving prostate cancer: What you need to know to make informed decisions

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84902931250     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book
Times cited : (1)

References (386)
  • 1
    • 84902931202 scopus 로고    scopus 로고
    • San Francisco: Encounter Books
    • David Horowitz, The End of Time (San Francisco: Encounter Books, 2005), 52.
    • (2005) The End of Time , pp. 52
    • Horowitz, D.1
  • 3
    • 5444263587 scopus 로고    scopus 로고
    • Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy
    • R. K. Nam, M. A. Jewett, M. D. Krahn, et al., Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy, Canadian Journal of Urology 10 (2003): 1891-98;
    • (2003) Canadian Journal of Urology , vol.10 , pp. 1891-1898
    • Nam, R.K.1    Jewett, M.A.2    Krahn, M.D.3
  • 4
    • 19744374856 scopus 로고    scopus 로고
    • Reasonable delay of surgical treatment in men with localized prostate cancer-impact on prognosis?
    • R. K. Nam, M. A. Jewett, M. D. Krahn, et al., Reasonable delay of surgical treatment in men with localized prostate cancer-impact on prognosis? European Urology 47 (2005): 756-760;
    • (2005) European Urology , vol.47 , pp. 756-760
    • Nam, R.K.1    Jewett, M.A.2    Krahn, M.D.3
  • 5
    • 25844481533 scopus 로고    scopus 로고
    • Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    • S. A. Boorjian, F. J. Bianco Jr., P. T. Scardino, et al., Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? British Journal of Urology 96 (2005): 773-776.
    • (2005) British Journal of Urology , vol.96 , pp. 773-776
    • Boorjian, S.A.1    Bianco Jr., F.J.2    Scardino, P.T.3
  • 6
    • 0002584538 scopus 로고    scopus 로고
    • The man's cancer
    • April 1, accessed September 19, 2005
    • Leon Jaroff, The man's cancer, Time, April 1, 1996, http://www.usrf.org/news/010815-Norman-Schwarzkopf-CaP.html, accessed September 19, 2005.
    • (1996) Time
    • Jaroff, L.1
  • 7
    • 24344508852 scopus 로고    scopus 로고
    • Awash in information, patients face a lonely, uncertain road
    • August 14
    • Jan Hoffman, Awash in information, patients face a lonely, uncertain road, New York Times, August 14, 2005.
    • (2005) New York Times
    • Hoffman, J.1
  • 8
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
    • I. M. Thompson, D. K. Pauler, P. J. Goodman, et al., Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter, New England Journal of Medicine 350 (2004): 2239-46
    • (2004) New England Journal of Medicine , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 10
    • 0345707585 scopus 로고    scopus 로고
    • Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (psa) levels < 10 ng/ml
    • A. J. Birtle, A. Freeman, J. R. W. Masters, et al., Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels [10 ng/mL, Cancer 98 (2003): 2362-67.
    • (2003) Cancer , vol.98 , pp. 2362-2367
    • Birtle, A.J.1    Freeman, A.2    Masters, J.R.W.3
  • 11
    • 0033493715 scopus 로고    scopus 로고
    • Prostate-specific antigen: Current status
    • M. K. Brawer, Prostate-specific antigen: current status, CA-A Cancer Journal for Clinicians 49 (1999): 264-281
    • (1999) CA-A Cancer Journal for Clinicians , vol.49 , pp. 264-281
    • Brawer, M.K.1
  • 13
    • 0026522840 scopus 로고
    • Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseases
    • H. B. Carter, J. D. Pearson, J. Metter, et al., Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseases, Journal of the American Medical Association 267 (1992): 2215-20.
    • (1992) Journal of the American Medical Association , vol.267 , pp. 2215-2220
    • Carter, H.B.1    Pearson, J.D.2    Metter, J.3
  • 14
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative psa ve locity and the risk of death from prostate cancer after radical prostatectomy
    • H. B. Carter, J. D. Pearson, J. Metter, et al., Preoperative PSA ve locity and the risk of death from prostate cancer after radical prostatectomy, New England Journal of Medicine 351 (2004): 125-135
    • (2004) New England Journal of Medicine , vol.351 , pp. 125-135
    • Carter, H.B.1    Pearson, J.D.2    Metter, J.3
  • 15
    • 22844433445 scopus 로고    scopus 로고
    • Pretreatment psa velocity and risk of death from prostate cancer following external beam radiation therapy
    • A. V. D'Amico, A. A. Renshaw, B. Sussman, et al., Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy, Journal of the American Medical Association 294 (2005): 440-447.
    • (2005) Journal of the American Medical Association , vol.294 , pp. 440-447
    • D'Amico, A.V.1    Renshaw, A.A.2    Sussman, B.3
  • 16
    • 3242755103 scopus 로고    scopus 로고
    • Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer
    • C. G. Ramos, K. A. Roehl, J. A. V. Antenor, et al., Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer, Journal of Urology 172 (2004): 137-140
    • (2004) Journal of Urology , vol.172 , pp. 137-140
    • Ramos, C.G.1    Roehl, K.A.2    Antenor, J.A.V.3
  • 17
    • 85047688844 scopus 로고    scopus 로고
    • Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer
    • L. E. Eichelberger, M. O. Koch, J. K. Daggy, et al., Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer, American Journal of Clinical Pathol ogy 120 (2003): 386-391
    • (2003) American Journal of Clinical Pathol Ogy , vol.120 , pp. 386-391
    • Eichelberger, L.E.1    Koch, M.O.2    Daggy, J.K.3
  • 18
  • 19
    • 0033787042 scopus 로고    scopus 로고
    • Prognostic significance of gleason score 3+4 versus gleason score 4+3 tumor at radical prostatectomy
    • T. Y. Chan, A. W. Partin, P. C. Walsh, et al., Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy, Urology 56 (2000): 823-827
    • (2000) Urology , vol.56 , pp. 823-827
    • Chan, T.Y.1    Partin, A.W.2    Walsh, P.C.3
  • 20
    • 19444364960 scopus 로고    scopus 로고
    • The combined percentage of gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy
    • L. Cheng, M. O. Koch, B. E. Juliar, et al., The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy, Journal of Clinical Oncology 23 (2005): 2911-17.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 2911-2917
    • Cheng, L.1    Koch, M.O.2    Juliar, B.E.3
  • 21
    • 0037304517 scopus 로고    scopus 로고
    • Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    • M. Han, A. W. Partin, M. Zahurak, et al., Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer, Journal of Urology 169 (2003): 517-523.
    • (2003) Journal of Urology , vol.169 , pp. 517-523
    • Han, M.1    Partin, A.W.2    Zahurak, M.3
  • 22
    • 2442694411 scopus 로고    scopus 로고
    • Correlation of the pri mary gleason pattern on prostate needle biopsy with clinico-pathological factors in gleason 7 tumors
    • E. D. Grober, J. Tsihlias, M. A. S. Jewett, et al., Correlation of the pri mary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors, Canadian Journal of Urology 11 (2004): 2157-62;
    • (2004) Canadian Journal of Urology , vol.11 , pp. 2157-2162
    • Grober, E.D.1    Tsihlias, J.2    Jewett, M.A.S.3
  • 23
    • 3242791771 scopus 로고    scopus 로고
    • Limitations of biopsy gleason grade: Implications for counseling patients with biopsy gleason score 6 prostate cancer
    • P. D. Sved, P. Gomez, M. Manoharan, et al., Limitations of biopsy Gleason grade: Implications for counseling patients with biopsy Gleason score 6 prostate cancer, Journal of Urology 172 (2004): 98-102;
    • (2004) Journal of Urology , vol.172 , pp. 98-102
    • Sved, P.D.1    Gomez, P.2    Manoharan, M.3
  • 24
    • 28244445598 scopus 로고    scopus 로고
    • Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer
    • P. Sooriakumaran, D. P. Lovell, A. Henderson, et al., Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer, Clinical Oncology 17 (2005): 655-658.
    • (2005) Clinical Oncology , vol.17 , pp. 655-658
    • Sooriakumaran, P.1    Lovell, D.P.2    Henderson, A.3
  • 25
    • 2442616955 scopus 로고    scopus 로고
    • The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy
    • Y. Lotan, S. F. Shariat, S. M. Khoddami, et al., The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy, Jour nal of Urology 171 (2004): 2209-14;
    • (2004) Jour Nal of Urology , vol.171 , pp. 2209-2214
    • Lotan, Y.1    Shariat, S.F.2    Khoddami, S.M.3
  • 26
    • 1642362437 scopus 로고    scopus 로고
    • Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen
    • I. F. San Francisco, M. M. Regan, A. F. Olumi, et al., Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen, Journal of Urology 171 (2004): 1492-99
    • (2004) Journal of Urology , vol.171 , pp. 1492-1499
    • San Francisco, I.F.1    Regan, M.M.2    Olumi, A.F.3
  • 27
    • 0344412952 scopus 로고    scopus 로고
    • The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy
    • S. J. Freedland, W. J. Aronson, M. K. Terris, et al., The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy, Cancer 98 (2003): 2344-50
    • (2003) Cancer , vol.98 , pp. 2344-2350
    • Freedland, S.J.1    Aronson, W.J.2    Terris, M.K.3
  • 28
    • 0036900782 scopus 로고    scopus 로고
    • Substratifica tion of stage t1c prostate cancer based on the probability of biochemical recurrence
    • M. B. Gretzer, J. I. Epstein, C. R. Pound, et al., Substratifica tion of Stage T1c prostate cancer based on the probability of biochemical recurrence, Urology 60 (2002): 1034-39;
    • (2002) Urology , vol.60 , pp. 1034-1039
    • Gretzer, M.B.1    Epstein, J.I.2    Pound, C.R.3
  • 29
    • 0034104315 scopus 로고    scopus 로고
    • Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
    • A. V. D'Amico, R. Whittington, S. B. Malkowicz, et al., Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer, Journal of Clinical Oncology 18 (2000): 1164-72
    • (2000) Journal of Clinical Oncology , vol.18 , pp. 1164-1172
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 30
    • 4644225078 scopus 로고    scopus 로고
    • Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease
    • A. V. D'Amico, A. A. Renshaw, K. Cote, et al., Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease, Journal of Clinical Oncology 22 (2004): 3726-32.
    • (2004) Journal of Clinical Oncology , vol.22 , pp. 3726-3732
    • D'Amico, A.V.1    Renshaw, A.A.2    Cote, K.3
  • 31
    • 4444232791 scopus 로고    scopus 로고
    • Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?
    • J. W. Anast, G. L. Andriole, T. A. Bismar, et al., Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population? Urology 64 (2004): 544-550
    • (2004) Urology , vol.64 , pp. 544-550
    • Anast, J.W.1    Andriole, G.L.2    Bismar, T.A.3
  • 32
    • 2942691916 scopus 로고    scopus 로고
    • Do younger men have better biochemical outcomes after radical prostatectomy?
    • S. J. Freedland, J. C. Presti Jr., C. J. Kane, et al., Do younger men have better biochemical outcomes after radical prostatectomy? Urology 63 (2004): 518-522.
    • (2004) Urology , vol.63 , pp. 518-522
    • Freedland, S.J.1    Presti Jr., J.C.2    Kane, C.J.3
  • 33
    • 0346217049 scopus 로고    scopus 로고
    • Is there age bias in the treatment of localized prostate carcinoma?
    • S. M. H. Alibhai, M. D. Krahn, M. M. Cohen, et al., Is there age bias in the treatment of localized prostate carcinoma? Cancer 100 (2004): 72-81.
    • (2004) Cancer , vol.100 , pp. 72-81
    • Alibhai, S.M.H.1    Krahn, M.D.2    Cohen, M.M.3
  • 34
    • 0347129587 scopus 로고    scopus 로고
    • Which conditions contributing to the charlson score predict survival after radical prostatectomy?
    • M. Froehner, R. Koch, R. Litz, et al., Which conditions contributing to the Charlson score predict survival after radical prostatectomy? Journal of Urology 171 (2004): 697-699
    • (2004) Journal of Urology , vol.171 , pp. 697-699
    • Froehner, M.1    Koch, R.2    Litz, R.3
  • 36
    • 16644401611 scopus 로고    scopus 로고
    • Laparoscopic radical prostatectomy: A review of the literature and comparison with open techniques
    • A. M. Omar and N. Townell, Laparoscopic radical prostatectomy: A review of the literature and comparison with open techniques, Prostate cancer and Prostatic Diseases 7 (2004): 295-301
    • (2004) Prostate cancer and Prostatic Diseases , vol.7 , pp. 295-301
    • Omar, A.M.1    Townell, N.2
  • 37
    • 84902901032 scopus 로고    scopus 로고
    • Men, cancer, and hope
    • November 1
    • R. Langreth, Men, cancer, and hope, Forbes, November 1, 2004.
    • (2004) Forbes
    • Langreth, R.1
  • 38
    • 0002584538 scopus 로고    scopus 로고
    • The man's cancer
    • April 1, accessed September 19, 2005
    • Leon Jaroff, The man's cancer, Time, April 1, 1996, http://www.usrf.org/news/010815-Norman-Schwarzkopf-CaP.html, accessed September 19, 2005.
    • (1996) Time
    • Jaroff, L.1
  • 41
    • 0037377020 scopus 로고    scopus 로고
    • A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer
    • M. Savoie, S. S. Kim, M. S. Soloway, A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer, Journal of Urology 169 (2003): 1462-64
    • (2003) Journal of Urology , vol.169 , pp. 1462-1464
    • Savoie, M.1    Kim, S.S.2    Soloway, M.S.3
  • 42
    • 0034805409 scopus 로고    scopus 로고
    • Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy
    • M. D. Munding, H. B. Wessells, B. L. Dalkin, Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy, Urology 58 (2001): 567-569
    • (2001) Urology , vol.58 , pp. 567-569
    • Munding, M.D.1    Wessells, H.B.2    Dalkin, B.L.3
  • 43
    • 84902944205 scopus 로고
    • New York: Cadell and Davies
    • William Martin, My Prostate and Me (New York: Cadell and Davies, 1994), 186
    • (1994) My Prostate and Me , pp. 186
    • Martin, W.1
  • 44
    • 0348109391 scopus 로고    scopus 로고
    • Re: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer (letter)
    • N. Mondaini and P. Gontero, Re: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer (letter), Journal of Urology 171 (2004): 359-360.
    • (2004) Journal of Urology , vol.171 , pp. 359-360
    • Mondaini, N.1    Gontero, P.2
  • 47
    • 27144558366 scopus 로고    scopus 로고
    • 30-day mortality and major complications after radical prostatectomy: Influence of age and comorbidity
    • S. M. H. Alibhai, M. Leach, G. Tomlinson, et al., 30-day mortality and major complications after radical prostatectomy: Influence of age and comorbidity, Journal of the National Cancer Institute 97 (2005): 1525-32.
    • (2005) Journal of the National Cancer Institute , vol.97 , pp. 1525-1532
    • Alibhai, S.M.H.1    Leach, M.2    Tomlinson, G.3
  • 48
    • 0031972670 scopus 로고    scopus 로고
    • Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
    • J. A. Talcott, P. Rieker, J. A. Clark, et al., Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study, Journal of Clinical Oncology 16 (1998): 275-283.
    • (1998) Journal of Clinical Oncology , vol.16 , pp. 275-283
    • Talcott, J.A.1    Rieker, P.2    Clark, J.A.3
  • 49
    • 0033957919 scopus 로고    scopus 로고
    • Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
    • P. C. Walsh, P. Marschke, D. Ricker, et al., Patient-reported urinary continence and sexual function after anatomic radical prostatectomy, Urology 55 (2000): 58-61
    • (2000) Urology , vol.55 , pp. 58-61
    • Walsh, P.C.1    Marschke, P.2    Ricker, D.3
  • 50
    • 0034685027 scopus 로고    scopus 로고
    • Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study
    • J. L. Stanford, Z. Feng, A. S. Hamilton, et al., Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study, Journal of the American Medical Association 283 (2000): 354-360;
    • (2000) Journal of the American Medical Association , vol.283 , pp. 354-360
    • Stanford, J.L.1    Feng, Z.2    Hamilton, A.S.3
  • 51
    • 0027141983 scopus 로고
    • Patient-reported complications and follow-up treatment after radical prostatectomy: The national medicare experience: 1988-1990
    • F. J. Fowler, M. J. Barry, G. Lu-Yao, et al., Patient-reported complications and follow-up treatment after radical prostatectomy: The National Medicare Experience: 1988-1990, Urology 42 (1993): 622-629
    • (1993) Urology , vol.42 , pp. 622-629
    • Fowler, F.J.1    Barry, M.J.2    Lu-Yao, G.3
  • 52
    • 0033951146 scopus 로고    scopus 로고
    • Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy
    • T. C. Kao, D. F. Cruess, D. Garner, et al., Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy, Journal of Urology 163 (2000): 858-864
    • (2000) Journal of Urology , vol.163 , pp. 858-864
    • Kao, T.C.1    Cruess, D.F.2    Garner, D.3
  • 53
    • 0347129585 scopus 로고    scopus 로고
    • Predicting quality of life after radical prostatectomy: Results from capsure
    • J. C. Hu, E. P. Elkin, D. J. Pasta, Predicting quality of life after radical prostatectomy: Results from CaPSURE, Journal of Urology 171 (2004): 703-708.
    • (2004) Journal of Urology , vol.171 , pp. 703-708
    • Hu, J.C.1    Elkin, E.P.2    Pasta, D.J.3
  • 54
    • 4344694747 scopus 로고    scopus 로고
    • Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer
    • B. K. Hollenbeck, R. L. Dunn, J. T. Wei, et al., Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer, Current Urology Reports 5 (2004): 212-219.
    • (2004) Current Urology Reports , vol.5 , pp. 212-219
    • Hollenbeck, B.K.1    Dunn, R.L.2    Wei, J.T.3
  • 55
    • 0347129566 scopus 로고    scopus 로고
    • Sildenafil preserves intracor poreal smooth muscle after radical retropubic prostatectomy
    • E. J. Schwartz, P. Wong, R. J. Graydon, Sildenafil preserves intracor poreal smooth muscle after radical retropubic prostatectomy, Journal of Urology 171 (2004): 771-774.
    • (2004) Journal of Urology , vol.171 , pp. 771-774
    • Schwartz, E.J.1    Wong, P.2    Graydon, R.J.3
  • 57
    • 3142653152 scopus 로고    scopus 로고
    • Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from capsure
    • M. S. Litwin, N. Sadetsky, D. J. Pasta, et al., Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE, Journal of Urology 172 (2004): 515-519.
    • (2004) Journal of Urology , vol.172 , pp. 515-519
    • Litwin, M.S.1    Sadetsky, N.2    Pasta, D.J.3
  • 58
    • 4143053657 scopus 로고    scopus 로고
    • Cancer progression and sur vival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
    • K. A. Roehl, M. Han, C. G. Ramos, et al., Cancer progression and sur vival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results, Journal of Urology 172 (2004): 910-914
    • (2004) Journal of Urology , vol.172 , pp. 910-914
    • Roehl, K.A.1    Han, M.2    Ramos, C.G.3
  • 59
    • 0345196579 scopus 로고    scopus 로고
    • Influence of age and prostate specific antigen on the chance of curable prostate cancer among men with nonpalpable disease
    • H. B. Carter, J. I. Epstein, A. W. Partin, Influence of age and prostate specific antigen on the chance of curable prostate cancer among men with nonpalpable disease, Urology 53 (1999): 126-130.
    • (1999) Urology , vol.53 , pp. 126-130
    • Carter, H.B.1    Epstein, J.I.2    Partin, A.W.3
  • 60
    • 0036900782 scopus 로고    scopus 로고
    • Substratification of stage t1c prostate cancer based on the probability of biochemical recurrence
    • M. B. Gretzer, J. I. Epstein, C. R. Pound, et al., Substratification of stage T1c prostate cancer based on the probability of biochemical recurrence, Urology 60 (2002): 1034-39
    • (2002) Urology , vol.60 , pp. 1034-1039
    • Gretzer, M.B.1    Epstein, J.I.2    Pound, C.R.3
  • 61
    • 0036719188 scopus 로고    scopus 로고
    • Long-term follow-up of radical retropubic prostatectomy for prostate cancer
    • G. P. Swanson, M. W. Riggs, J. D. Earle, et al., Long-term follow-up of radical retropubic prostatectomy for prostate cancer, European Urology 42 (2002): 212-216.
    • (2002) European Urology , vol.42 , pp. 212-216
    • Swanson, G.P.1    Riggs, M.W.2    Earle, J.D.3
  • 62
    • 0036141891 scopus 로고    scopus 로고
    • Cancer control with radical prostatectomy alone in 1,000 consecutive patients
    • G. W. Hull, F. Rabbani, F. Abbas, et al., Cancer control with radical prostatectomy alone in 1,000 consecutive patients, Journal of Urology 67 (2002): 528-534
    • (2002) Journal of Urology , vol.67 , pp. 528-534
    • Hull, G.W.1    Rabbani, F.2    Abbas, F.3
  • 63
    • 0027997867 scopus 로고
    • Long-term (15 years) results after radical prostatectomy for clinically localized (stage t2c or lower) prostate cancer
    • H. Zincke, J. E. Oesterling, M. L. Blute, et al., Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer, Journal of Urology 152 (1994): 1850-57
    • (1994) Journal of Urology , vol.152 , pp. 1850-1857
    • Zincke, H.1    Oesterling, J.E.2    Blute, M.L.3
  • 64
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy
    • M. Han, A. W. Partin, C. R. Pound, et al., Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy, Urologic Clinics of North America 28 (2001): 555-565;
    • (2001) Urologic Clinics of North America , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3
  • 65
    • 0036645258 scopus 로고    scopus 로고
    • Mental health in men treated for early stage prostate carcinoma: A posttreatment, longitudinal quality of life analysis from the cancer of the prostate strategic urologic research endeavor
    • M. S. Litwin, D. P. Lubeck, G. M. Spitalny, et al., Mental health in men treated for early stage prostate carcinoma: A posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor, Cancer 95 (2002): 54-60.
    • (2002) Cancer , vol.95 , pp. 54-60
    • Litwin, M.S.1    Lubeck, D.P.2    Spitalny, G.M.3
  • 66
    • 0842306321 scopus 로고    scopus 로고
    • Development of prostate cancer treat ment: The good news
    • S. R. Denmeade and J. T. Isaacs, Development of prostate cancer treat ment: The good news, Prostate 58 (2004): 211-224.
    • (2004) Prostate , vol.58 , pp. 211-224
    • Denmeade, S.R.1    Isaacs, J.T.2
  • 68
    • 4444334500 scopus 로고    scopus 로고
    • Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer, international journal of radiation oncology, biology
    • W. W. Wong, S. E. Schild, S. A. Vora, et al., Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer, International Journal of Radiation Oncology, Biology, Physics 60 (2004): 24-29.
    • (2004) Physics , vol.60 , pp. 24-29
    • Wong, W.W.1    Schild, S.E.2    Vora, S.A.3
  • 69
    • 0346217049 scopus 로고    scopus 로고
    • Is there age bias in the treatment of localized prostate carcinoma?
    • S. M. Alibhai, M. D. Krahn, M. M. Cohen, et al., Is there age bias in the treatment of localized prostate carcinoma? Cancer 100 (2004): 72-81.
    • (2004) Cancer , vol.100 , pp. 72-81
    • Alibhai, S.M.1    Krahn, M.D.2    Cohen, M.M.3
  • 70
    • 23744493443 scopus 로고    scopus 로고
    • Postoperative radio therapy after radical prostatectomy: A randomized controlled trial (eortc trial 22911)
    • M. Bolla, H. van Poppel, P. van Cangh, et al., Postoperative radio therapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911), Lancet 366 (2005): 572-578.
    • (2005) Lancet , vol.366 , pp. 572-578
    • Bolla, M.1    van Poppel, H.2    van Cangh, P.3
  • 71
    • 3242812898 scopus 로고    scopus 로고
    • A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma
    • Phyllis M. Windsor, Kathleen F. Nicol, Joan Potter, A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma, Cancer 101 (2004): 550-557.
    • (2004) Cancer , vol.101 , pp. 550-557
    • Windsor, P.M.1    Nicol, K.F.2    Potter, J.3
  • 72
    • 0344844487 scopus 로고    scopus 로고
    • Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy
    • I. Staff, A. Salner, R. Bohannon, et al., Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy, Cancer 98 (2003): 2335-43.
    • (2003) Cancer , vol.98 , pp. 2335-2343
    • Staff, I.1    Salner, A.2    Bohannon, R.3
  • 74
    • 0036136707 scopus 로고    scopus 로고
    • Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer
    • B. G. Gardner, A. L. Zietman, W. U. Shipley, et al., Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer, Journal of Urology 167 (2002): 123-126.
    • (2002) Journal of Urology , vol.167 , pp. 123-126
    • Gardner, B.G.1    Zietman, A.L.2    Shipley, W.U.3
  • 75
    • 0037080315 scopus 로고    scopus 로고
    • Comprehensive com parison of health-related quality of life after contemporary therapies for localized prostate cancer
    • J. T. Wei, R. L. Dunn, H. M. Sandler, et al., Comprehensive com parison of health-related quality of life after contemporary therapies for localized prostate cancer, Journal of Clinical Oncology 20 (2002): 557-566;
    • (2002) Journal of Clinical Oncology , vol.20 , pp. 557-566
    • Wei, J.T.1    Dunn, R.L.2    Sandler, H.M.3
  • 76
    • 0034947339 scopus 로고    scopus 로고
    • Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients pre viously treated
    • J. A. Talcott, J. A. Clark, P. C. Stark, Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients pre viously treated, Journal of Urology 166 (2001): 494-499
    • (2001) Journal of Urology , vol.166 , pp. 494-499
    • Talcott, J.A.1    Clark, J.A.2    Stark, P.C.3
  • 78
    • 4644287961 scopus 로고    scopus 로고
    • Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
    • A. L. Potosky, W. W. Davis, R. M. Hoffman, et al., Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The Prostate Cancer Outcomes Study, Journal of the National Cancer Institute 96 (2004): 1358-67.
    • (2004) Journal of the National Cancer Institute , vol.96 , pp. 1358-1367
    • Potosky, A.L.1    Davis, W.W.2    Hoffman, R.M.3
  • 79
    • 0030944404 scopus 로고    scopus 로고
    • Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer, international journal of radiation oncology, biology
    • C. A. Mantz, P. Song, E. Farhangi, et al., Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer, International Journal of Radiation Oncology, Biology, Physics 37 (1997): 551-557;
    • (1997) Physics , vol.37 , pp. 551-557
    • Mantz, C.A.1    Song, P.2    Farhangi, E.3
  • 80
    • 0032816747 scopus 로고    scopus 로고
    • Sexual func tion and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from capsure
    • M. S. Litwin, S. C. Flanders, D. J. Pasta, et al., Sexual func tion and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE, Urology 54 (1999): 503-508
    • (1999) Urology , vol.54 , pp. 503-508
    • Litwin, M.S.1    Flanders, S.C.2    Pasta, D.J.3
  • 81
    • 0141919741 scopus 로고    scopus 로고
    • Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from capsure
    • T. M. Downs, N. Sadetsky, D. J. Pasta, et al., Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from CaPSURE, Journal of Urology 170 (2003): 1822-27;
    • (2003) Journal of Urology , vol.170 , pp. 1822-1827
    • Downs, T.M.1    Sadetsky, N.2    Pasta, D.J.3
  • 82
    • 23744501076 scopus 로고    scopus 로고
    • Cross-sectional analysis of sexual function after prostate brachytherapy
    • T. M. Downs, N. Sadetsky, D. J. Pasta, et al., Cross-sectional analysis of sexual function after prostate brachytherapy, Urology 66 (2005): 377-381
    • (2005) Urology , vol.66 , pp. 377-381
    • Downs, T.M.1    Sadetsky, N.2    Pasta, D.J.3
  • 83
    • 4344694747 scopus 로고    scopus 로고
    • Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer
    • B. K. Hollenbeck, R. L. Dunn, J. T. Wei, et al., Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer, Current Urology Reports 5 (2004): 212-219;
    • (2004) Current Urology Reports , vol.5 , pp. 212-219
    • Hollenbeck, B.K.1    Dunn, R.L.2    Wei, J.T.3
  • 84
    • 0037108282 scopus 로고    scopus 로고
    • Defining sexual outcomes after treatment for localized prostate carcinoma
    • L. R. Schover, R. T. Fouladi, C. L. Warneke, et al., Defining sexual outcomes after treatment for localized prostate carcinoma, Cancer 95 (2002): 1773-85;
    • (2002) Cancer , vol.95 , pp. 1773-1785
    • Schover, L.R.1    Fouladi, R.T.2    Warneke, C.L.3
  • 85
    • 1542267898 scopus 로고    scopus 로고
    • High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds
    • I. S. Grills, A. A. Martinez, M. Hollander, et al., High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds, Journal of Urology 171 (2004): 1098-1104.
    • (2004) Journal of Urology , vol.171 , pp. 1098-1104
    • Grills, I.S.1    Martinez, A.A.2    Hollander, M.3
  • 86
    • 17144428905 scopus 로고    scopus 로고
    • Increased risk of rectal cancer after prostate radiation: A population-based study
    • N. N. Baxter, J. E. Tepper, S. B. Durham, et al., Increased risk of rectal cancer after prostate radiation: A population-based study, Gastroenterology 128 (2005): 819-824.
    • (2005) Gastroenterology , vol.128 , pp. 819-824
    • Baxter, N.N.1    Tepper, J.E.2    Durham, S.B.3
  • 87
    • 3142653152 scopus 로고    scopus 로고
    • Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from capsure
    • M. S. Litwin, N. Sadetsky, D. J. Pasta, et al., Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE, Journal of Urology 172 (2004): 515-519;
    • (2004) Journal of Urology , vol.172 , pp. 515-519
    • Litwin, M.S.1    Sadetsky, N.2    Pasta, D.J.3
  • 88
    • 0034891284 scopus 로고    scopus 로고
    • High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
    • M. J. Zelefsky, Z. Fuks, M. Hunt, et al., High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer, Journal of Urology 166 (2001): 876-881.
    • (2001) Journal of Urology , vol.166 , pp. 876-881
    • Zelefsky, M.J.1    Fuks, Z.2    Hunt, M.3
  • 89
    • 0036603607 scopus 로고    scopus 로고
    • Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer, international journal of radiation oncology, biology
    • A. L. Hanlon, H. Diratzouian, G. E. Hanks, et al., Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer, International Journal of Radiation Oncology, Biology, Physics 53 (2002): 297-303
    • (2002) Physics , vol.53 , pp. 297-303
    • Hanlon, A.L.1    Diratzouian, H.2    Hanks, G.E.3
  • 90
    • 0036165226 scopus 로고    scopus 로고
    • A standard definition of disease freedom is needed for prostate cancer: Undetectable prostate specific antigen compared with the american society of therapeutic radiology and oncology consensus definition
    • F. A. Critz, A standard definition of disease freedom is needed for prostate cancer: Undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition, Journal of Urology 167 (2002): 1310-13.
    • (2002) Journal of Urology , vol.167 , pp. 1310-1313
    • Critz, F.A.1
  • 91
    • 22844433445 scopus 로고    scopus 로고
    • Pretreatment psa velocity and risk of death from prostate cancer following external beam radiation therapy
    • A. V. D'Amico, A. A. Renshaw, B. Sussman, et al., Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy, Journal of the American Medical Association 294 (2005): 440-447.
    • (2005) Journal of the American Medical Association , vol.294 , pp. 440-447
    • D'Amico, A.V.1    Renshaw, A.A.2    Sussman, B.3
  • 92
    • 0038286475 scopus 로고    scopus 로고
    • Regret in men treated for localized prostate cancer
    • J. C. Hu, L. Kwan, C. S. Saigal, et al., Regret in men treated for localized prostate cancer, Journal of Urology 169 (2003): 2279-83.
    • (2003) Journal of Urology , vol.169 , pp. 2279-2283
    • Hu, J.C.1    Kwan, L.2    Saigal, C.S.3
  • 93
    • 0042463650 scopus 로고    scopus 로고
    • National prac tice patterns and time trends in androgen ablation for localized prostate cancer
    • M. R. Cooperberg, G. D. Grossfeld, D. P. Lubeck, et al., National prac tice patterns and time trends in androgen ablation for localized prostate cancer, Journal of the National Cancer Institute 95 (2003): 981-989.
    • (2003) Journal of the National Cancer Institute , vol.95 , pp. 981-989
    • Cooperberg, M.R.1    Grossfeld, G.D.2    Lubeck, D.P.3
  • 94
    • 17144380470 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for biologic recurrence after radical prostatectomy: Long-term experience
    • M. Peyromaure, N. B. Delongchamps, B. Debré, et al., Intermittent androgen deprivation for biologic recurrence after radical prostatectomy: Long-term experience, Urology 65 (2005): 724-729.
    • (2005) Urology , vol.65 , pp. 724-729
    • Peyromaure, M.1    Delongchamps, N.B.2    Debré, B.3
  • 95
    • 0033992101 scopus 로고    scopus 로고
    • Progressive osteo porosis during androgen deprivation therapy for prostate cancer
    • H. W. Daniell, S. R. Dunn, D. W. Ferguson, et al., Progressive osteo porosis during androgen deprivation therapy for prostate cancer, Journal of Urology 163 (2000): 181-186.
    • (2000) Journal of Urology , vol.163 , pp. 181-186
    • Daniell, H.W.1    Dunn, S.R.2    Ferguson, D.W.3
  • 96
    • 11844252588 scopus 로고    scopus 로고
    • Risk of fracture after androgen deprivation for prostate cancer
    • H. W. Daniell, S. R. Dunn, D. W. Ferguson, et al., Risk of fracture after androgen deprivation for prostate cancer, New England Journal of Medicine 352 (2005): 154-164.
    • (2005) New England Journal of Medicine , vol.352 , pp. 154-164
    • Daniell, H.W.1    Dunn, S.R.2    Ferguson, D.W.3
  • 97
    • 0141887365 scopus 로고    scopus 로고
    • Androgen deprivation and cognition in prostate cancer
    • E. Salminen, R. Portin, J. Korpela, et al., Androgen deprivation and cognition in prostate cancer, British Journal of Cancer 89 (2003): 971-976.
    • (2003) British Journal of Cancer , vol.89 , pp. 971-976
    • Salminen, E.1    Portin, R.2    Korpela, J.3
  • 98
    • 0037072063 scopus 로고    scopus 로고
    • Long-term results with immedi ate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an eortc study): A phase III randomised trial
    • M. Bolla, L. Collette, L. Blank, et al., Long-term results with immedi ate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial, Lancet 360 (2002): 103-108.
    • (2002) Lancet , vol.360 , pp. 103-108
    • Bolla, M.1    Collette, L.2    Blank, L.3
  • 99
    • 0035869725 scopus 로고    scopus 로고
    • Updated results of the phase iii radiation therapy oncology group (rtog) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate, international journal of radiation oncology, biology
    • C. A. Lawton, K. Winter, K. Murray, et al., Updated results of the Phase III Radiation Therapy Oncology Group (RTOG) Trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate, International Journal of Radiation Oncology, Biology, Physics 49 (2001): 937-946;
    • (2001) Physics , vol.49 , pp. 937-946
    • Lawton, C.A.1    Winter, K.2    Murray, K.3
  • 100
    • 0035424063 scopus 로고    scopus 로고
    • Phase iii radiation therapy oncology group (rtog) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, inter national journal of radiation oncology, biology
    • M. V. Pilepich, K. Winter, M. J. John, et al., Phase III Radiation Therapy Oncology Group (RTOG) Trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, Inter national Journal of Radiation Oncology, Biology, Physics 50 (2001): 1243-52;
    • (2001) Physics , vol.50 , pp. 1243-1252
    • Pilepich, M.V.1    Winter, K.2    John, M.J.3
  • 101
    • 0642311912 scopus 로고    scopus 로고
    • Phase iii trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The radiation ther-apy outcome group protocol 92-02
    • G. E. Hanks, T. F. Pajak, A. Porter, et al., Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Ther-apy Outcome Group Protocol 92-02, Journal of Clinical Oncology 21 (2003): 3972-78
    • (2003) Journal of Clinical Oncology , vol.21 , pp. 3972-3978
    • Hanks, G.E.1    Pajak, T.F.2    Porter, A.3
  • 102
    • 4043153049 scopus 로고    scopus 로고
    • 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer
    • A. V. D'Amico, J. Manola, M. Loffredo, et al., 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer, Journal of the American Medical Association 292 (2004): 821-827.
    • (2004) Journal of the American Medical Association , vol.292 , pp. 821-827
    • D'Amico, A.V.1    Manola, J.2    Loffredo, M.3
  • 103
    • 0041857999 scopus 로고    scopus 로고
    • Early prostate cancer: Prevention, treatment modalities, and quality of life issues
    • J. W. Moul, J. Anderson, D. F. Penson, et al., Early prostate cancer: Prevention, treatment modalities, and quality of life issues, European Urology 44 (2003): 283-293
    • (2003) European Urology , vol.44 , pp. 283-293
    • Moul, J.W.1    Anderson, J.2    Penson, D.F.3
  • 104
    • 0036071805 scopus 로고    scopus 로고
    • Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program
    • W. A. See, M. P. Wirth, D. G. McLeod, et al., Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program, Journal of Urology 168 (2002): 429-435.
    • (2002) Journal of Urology , vol.168 , pp. 429-435
    • See, W.A.1    Wirth, M.P.2    McLeod, D.G.3
  • 105
    • 0036135882 scopus 로고    scopus 로고
    • Neoadjuvant androgen ablation before radical prostatectomy in ct2bnxm0 prostate cancer: 5-year results
    • M. S. Soloway, K. Pareek, R. Sharifi, et al., Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxM0 prostate cancer: 5-year results, Journal of Urology 167 (2002): 112-116
    • (2002) Journal of Urology , vol.167 , pp. 112-116
    • Soloway, M.S.1    Pareek, K.2    Sharifi, R.3
  • 106
    • 0032831990 scopus 로고    scopus 로고
    • Quality of life after salvage cryotherapy: The impact of treatment parameters
    • P. Perrotte, M. S. Litwin, E. J. McGuire, et al., Quality of life after salvage cryotherapy: The impact of treatment parameters, Journal of Urology 162 (1999): 398-402
    • (1999) Journal of Urology , vol.162 , pp. 398-402
    • Perrotte, P.1    Litwin, M.S.2    McGuire, E.J.3
  • 107
    • 0042191828 scopus 로고    scopus 로고
    • Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience
    • K.-R. Han, J. K. Cohen, R. J. Miller, et al., Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience, Journal of Urology 170 (2003): 1126-30
    • (2003) Journal of Urology , vol.170 , pp. 1126-1130
    • Han, K.-R.1    Cohen, J.K.2    Miller, R.J.3
  • 109
    • 0035129604 scopus 로고    scopus 로고
    • Five-year retrospective, multi institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate
    • J. P. Long, D. Bahn, F. Lee, et al., Five-year retrospective, multi institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate, Urology 57 (2001): 518-523;
    • (2001) Urology , vol.57 , pp. 518-523
    • Long, J.P.1    Bahn, D.2    Lee, F.3
  • 110
    • 0036706468 scopus 로고    scopus 로고
    • Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer
    • D. K. Bahn, F. Lee, R. Badalament, et al., Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer, Urology 60 (2 suppl. 1) (2002): 3-11.
    • (2002) Urology , vol.60 , Issue.2 SUPPL. 1 , pp. 3-11
    • Bahn, D.K.1    Lee, F.2    Badalament, R.3
  • 111
    • 0033572780 scopus 로고    scopus 로고
    • Alternative medicine use in patients with localized prostate carcinoma treated with curative intent
    • M. C. Lippert, R. McClain, J. C. Boyd, et al., Alternative medicine use in patients with localized prostate carcinoma treated with curative intent, Cancer 86 (1999): 2642-48.
    • (1999) Cancer , vol.86 , pp. 2642-2648
    • Lippert, M.C.1    McClain, R.2    Boyd, J.C.3
  • 112
    • 0037907251 scopus 로고    scopus 로고
    • Motivations and influ ences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: Results of a pilot study
    • J. D. Hall, E. A. Bissonette, J. C. Boyd, et al., Motivations and influ ences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: Results of a pilot study, BJU Inter national 91 (2003): 603-607;
    • (2003) BJU Inter National , vol.91 , pp. 603-607
    • Hall, J.D.1    Bissonette, E.A.2    Boyd, J.C.3
  • 113
    • 0036896455 scopus 로고    scopus 로고
    • Attitudes and use of complementary medicine in men with prostate cancer
    • S. Wilkinson, L. G. Gomella, J. A. Smith, et al., Attitudes and use of complementary medicine in men with prostate cancer, Journal of Urology 168 (2002): 2505-9;
    • (2002) Journal of Urology , vol.168 , pp. 2505-2509
    • Wilkinson, S.1    Gomella, L.G.2    Smith, J.A.3
  • 114
    • 1242296771 scopus 로고    scopus 로고
    • Herbal and vitamin supplement use in a prostate cancer screening population
    • A. Barqawi, E. Gamito, C. O'Donnell, et al., Herbal and vitamin supplement use in a prostate cancer screening population, Urology 63 (2004): 288-292;
    • (2004) Urology , vol.63 , pp. 288-292
    • Barqawi, A.1    Gamito, E.2    O'Donnell, C.3
  • 115
    • 0032850112 scopus 로고    scopus 로고
    • Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis
    • R. K. Nam, N. Fleshner, E. Rakovitch, et al., Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis, Journal of Urology 161 (1999): 1521-24.
    • (1999) Journal of Urology , vol.161 , pp. 1521-1524
    • Nam, R.K.1    Fleshner, N.2    Rakovitch, E.3
  • 116
    • 0033548049 scopus 로고    scopus 로고
    • Saw palmetto for benign prostatic hyperplasia
    • Saw palmetto for benign prostatic hyperplasia, Medical Letter 41 (1999): 18.
    • (1999) Medical Letter , vol.41 , pp. 18
  • 117
    • 0242495792 scopus 로고    scopus 로고
    • Use of complementary/alter native medicine by men diagnosed with prostate cancer: Prevalence and characteristics
    • H. Boon, K. Westlake, M. Stewart, et al., Use of complementary/alter native medicine by men diagnosed with prostate cancer: Prevalence and characteristics, Urology 62 (2003): 849-853
    • (2003) Urology , vol.62 , pp. 849-853
    • Boon, H.1    Westlake, K.2    Stewart, M.3
  • 118
    • 0141762650 scopus 로고    scopus 로고
    • A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer
    • J. Eng, D. Ramsum, M. Verhoef, et al., A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer, Integrative Cancer Therapies 2 (2003); 212-216;
    • (2003) Integrative Cancer Therapies , vol.2 , pp. 212-216
    • Eng, J.1    Ramsum, D.2    Verhoef, M.3
  • 119
    • 1242319248 scopus 로고    scopus 로고
    • Use of complementary and alternative medicine in men with family history of prostate cancer: A pilot study
    • J. L. Beebe-Dimmer, D. P. Wood Jr., S. B. Gruber, et al., Use of complementary and alternative medicine in men with family history of prostate cancer: A pilot study, Urology 63 (2004): 282-287.
    • (2004) Urology , vol.63 , pp. 282-287
    • Beebe-Dimmer, J.L.1    Wood Jr., D.P.2    Gruber, S.B.3
  • 120
    • 0036789223 scopus 로고    scopus 로고
    • Complementary and alterna tive medicine use among men with prostate cancer in 4 ethnic populations
    • M. M. Lee, J. S. Chang, B. Jacobs, et al., Complementary and alterna tive medicine use among men with prostate cancer in 4 ethnic populations, American Journal of Public Health 92 (2002): 1606-9.
    • (2002) American Journal of Public Health , vol.92 , pp. 1606-1609
    • Lee, M.M.1    Chang, J.S.2    Jacobs, B.3
  • 122
    • 3042728725 scopus 로고    scopus 로고
    • Rasagenthi lehyam (rl) a novel complementary and alternative medicine for prostate cancer
    • D. Schardt, Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer, Cancer Chemotherapy and Pharmacology 54 (2004): 7-15.
    • (2004) Cancer Chemotherapy and Pharmacology , vol.54 , pp. 7-15
    • Schardt, D.1
  • 123
    • 0031765890 scopus 로고    scopus 로고
    • Phase i/ii trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer
    • D. R. Miller, G. T. Anderson, J. J. Stark, et al., Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer, Journal of Clinical Oncology 16 (1998): 3649-55.
    • (1998) Journal of Clinical Oncology , vol.16 , pp. 3649-3655
    • Miller, D.R.1    Anderson, G.T.2    Stark, J.J.3
  • 125
    • 84884451952 scopus 로고    scopus 로고
    • West bury, N.Y.: Health Education Literary Publisher
    • James Lewis, The Herbal Remedy for Prostate Cancer (West bury, N.Y.: Health Education Literary Publisher, 1999), 41.
    • (1999) The Herbal Remedy for Prostate Cancer , pp. 41
    • Lewis, J.1
  • 128
    • 0036970935 scopus 로고    scopus 로고
    • Complementary and alternative therapies in prostate cancer
    • W. K. Oh and E. J. Small, Complementary and alternative therapies in prostate cancer, Seminars in Oncology 29 (2002): 575-584
    • (2002) Seminars in Oncology , vol.29 , pp. 575-584
    • Oh, W.K.1    Small, E.J.2
  • 129
    • 32144437818 scopus 로고    scopus 로고
    • Herbal remedies turn deadly for patients
    • September 5
    • J. Gillis, Herbal remedies turn deadly for patients, Washington Post, September 5, 2004.
    • (2004) Washington Post
    • Gillis, J.1
  • 130
    • 4644250900 scopus 로고    scopus 로고
    • Prospective, multicenter, randomized phase ii trial of the herbal supplement, pc-spes, and diethylstilbestrol in patients with androgen-independent prostate cancer
    • W. K. Oh, P. W. Kantoff, V. Weinberg, et al., Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer, Journal of Clinical Oncology 22 (2004): 3705-12;
    • (2004) Journal of Clinical Oncology , vol.22 , pp. 3705-3712
    • Oh, W.K.1    Kantoff, P.W.2    Weinberg, V.3
  • 131
    • 0002405120 scopus 로고    scopus 로고
    • Taking on prostate cancer
    • May 13
    • A. Grove, Taking on prostate cancer, Fortune, May 13, 1996.
    • (1996) Fortune
    • Grove, A.1
  • 132
    • 84902921357 scopus 로고    scopus 로고
    • Tx delay raises risk in patients with high-risk pca
    • May 1
    • M. Overmyer, Tx delay raises risk in patients with high-risk PCa, Urology Times, May 1, 2004.
    • (2004) Urology Times
    • Overmyer, M.1
  • 135
    • 0037068646 scopus 로고    scopus 로고
    • A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer
    • L. Holmberg, A. Bill-Axelson, F. Helgesen, et al., A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer, New England Journal of Medicine 347 (2002): 781-789.
    • (2002) New England Journal of Medicine , vol.347 , pp. 781-789
    • Holmberg, L.1    Bill-Axelson, A.2    Helgesen, F.3
  • 136
    • 0028158141 scopus 로고
    • Results of conserva tive management of clinically localized prostate cancer
    • G. W. Chodak, R. A. Thisted, G. S. Gerber, et al., Results of conserva tive management of clinically localized prostate cancer, New England Journal of Medicine 330 (1994): 242-248.
    • (1994) New England Journal of Medicine , vol.330 , pp. 242-248
    • Chodak, G.W.1    Thisted, R.A.2    Gerber, G.S.3
  • 137
    • 17844402699 scopus 로고    scopus 로고
    • 20-year outcomes following conservative management of clinically localized prostate cancer
    • P. C. Albertsen, J. A. Hanley, and J. Fine, 20-year outcomes following conservative management of clinically localized prostate cancer, Journal of the American Medical Association 293 (2005): 2095-2101.
    • (2005) Journal of the American Medical Association , vol.293 , pp. 2095-2101
    • Albertsen, P.C.1    Hanley, J.A.2    Fine, J.3
  • 138
    • 0037068634 scopus 로고    scopus 로고
    • Quality of life after radi cal prostatectomy or watchful waiting
    • G. Steineck, F. Helgesen, J. Adolfsson, et al., Quality of life after radi cal prostatectomy or watchful waiting, New England Journal of Medicine 347 (2002): 790-796
    • (2002) New England Journal of Medicine , vol.347 , pp. 790-796
    • Steineck, G.1    Helgesen, F.2    Adolfsson, J.3
  • 139
    • 0032402113 scopus 로고    scopus 로고
    • Urinary symptoms, potency, and quality of life in patients with localized prostate cancer fol lowed up with deferred treatment
    • M. Jønler, O. S. Nielsen, and H. Wolf, Urinary symptoms, potency, and quality of life in patients with localized prostate cancer fol lowed up with deferred treatment, Urology 52 (1998): 1055-62
    • (1998) Urology , vol.52 , pp. 1055-1062
    • Jønler, M.1    Nielsen, O.S.2    Wolf, H.3
  • 140
    • 5444238520 scopus 로고    scopus 로고
    • Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from capsure
    • S. A. Ar redondo, T. M. Downs, D. P. Lubeck, et al., Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE, Journal of Urology 172 (2004): 1830-34.
    • (2004) Journal of Urology , vol.172 , pp. 1830-1834
    • Ar redondo, S.A.1    Downs, T.M.2    Lubeck, D.P.3
  • 141
    • 0344011550 scopus 로고    scopus 로고
    • Follow-up of conservatively man aged prostate cancer: Watchful waiting and primary hormonal therapy
    • E. M. Messing and I. Thompson Jr., Follow-up of conservatively man aged prostate cancer: Watchful waiting and primary hormonal therapy, Urologic Clinics of North America 30 (2003): 687-702
    • (2003) Urologic Clinics of North America , vol.30 , pp. 687-702
    • Messing, E.M.1    Thompson Jr., I.2
  • 142
    • 23744506376 scopus 로고    scopus 로고
    • Intensive lifestyle changes may affect the progression of prostate cancer
    • D. Ornish, G. Weidner, W. R. Fair, et al., Intensive lifestyle changes may affect the progression of prostate cancer, Journal of Urology 174 (2005): 1065-70.
    • (2005) Journal of Urology , vol.174 , pp. 1065-1070
    • Ornish, D.1    Weidner, G.2    Fair, W.R.3
  • 143
    • 0002584538 scopus 로고    scopus 로고
    • The man's cancer
    • April 1
    • Leon Jaroff, The man's cancer, Time, April 1, 1996
    • (1996) Time
    • Jaroff, L.1
  • 144
    • 4344639269 scopus 로고    scopus 로고
    • Patterns of practice in the united states: Insights from capsure on prostate cancer management
    • M. R. Cooper berg, J. M. Broering, D. M. Latini, et al., Patterns of practice in the United States: Insights from CaPSURE on prostate cancer management, Current Urol ogy Reports 5 (2004): 166-172;
    • (2004) Current Urol Ogy Reports , vol.5 , pp. 166-172
    • Cooperberg, M.R.1    Broering, J.M.2    Latini, D.M.3
  • 145
    • 0141919735 scopus 로고    scopus 로고
    • Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from capsure
    • S. R. Harlan, M. R. Cooperberg, E. P. Elkin, et al., Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE, Journal of Urology 170 (2003): 1804-7.
    • (2003) Journal of Urology , vol.170 , pp. 1804-1807
    • Harlan, S.R.1    Cooperberg, M.R.2    Elkin, E.P.3
  • 146
    • 12144289009 scopus 로고    scopus 로고
    • Watchful waiting and factors pre dictive of secondary treatment of localized prostate cancer
    • H. Wu, L. Sun, J. W. Moul, et al., Watchful waiting and factors pre dictive of secondary treatment of localized prostate cancer, Journal of Urology 171 (2004): 1111-16.
    • (2004) Journal of Urology , vol.171 , pp. 1111-1116
    • Wu, H.1    Sun, L.2    Moul, J.W.3
  • 149
    • 16544384379 scopus 로고    scopus 로고
    • Whitmorisms [letter]
    • J. A. Kaswick, Whitmorisms [letter], Urology 64 (2004): 189.
    • (2004) Urology , vol.64 , pp. 189
    • Kaswick, J.A.1
  • 150
    • 0345530851 scopus 로고    scopus 로고
    • Still waiting on watchful waiting: Clinical trials test surveillance
    • C. Bankhead, Still waiting on watchful waiting: Clinical trials test surveillance, Journal of the National Cancer Institute 95 (2003): 1657-59;
    • (2003) Journal of the National Cancer Institute , vol.95 , pp. 1657-1659
    • Bankhead, C.1
  • 151
    • 0642342662 scopus 로고    scopus 로고
    • Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era
    • C. A. Carter, T. Donahue, L. Sun, et al., Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era, Journal of Clinical Oncology 21 (2003): 4001-8;
    • (2003) Journal of Clinical Oncology , vol.21 , pp. 4001-4008
    • Carter, C.A.1    Donahue, T.2    Sun, L.3
  • 152
    • 1642310441 scopus 로고    scopus 로고
    • An analysis of men with clinically localized prostate cancer who deferred definitive therapy
    • C. A. Carter, T. Donahue, L. Sun, et al., An analysis of men with clinically localized prostate cancer who deferred definitive therapy, Journal of Urology 171 (2004): 1520-24.
    • (2004) Journal of Urology , vol.171 , pp. 1520-1524
    • Carter, C.A.1    Donahue, T.2    Sun, L.3
  • 153
    • 0037422846 scopus 로고    scopus 로고
    • Obesity in adulthood and its consequences for life expectancy: A life-table analysis
    • A. Peeters, J. J. Barendregt, F. Willekens, et al., Obesity in adulthood and its consequences for life expectancy: A life-table analysis, Annals of Internal Medicine 138 (2003): 24-32.
    • (2003) Annals of Internal Medicine , vol.138 , pp. 24-32
    • Peeters, A.1    Barendregt, J.J.2    Willekens, F.3
  • 154
    • 0141885276 scopus 로고    scopus 로고
    • Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from capsure
    • S. S. Mehta, D. P. Lubeck, D. J. Pasta, et al., Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE, Journal of Urology 170 (2003): 1931-33
    • (2003) Journal of Urology , vol.170 , pp. 1931-1933
    • Mehta, S.S.1    Lubeck, D.P.2    Pasta, D.J.3
  • 155
    • 0036645258 scopus 로고    scopus 로고
    • Mental health in men treated for early stage prostate carcinoma: A posttreatment, longitudinal quality of life analysis from the cancer of the prostate strategic urologic research endeavor
    • M. S. Litwin, D. P. Lubeck, G. M. Spitalny, et al., Mental health in men treated for early stage prostate carcinoma: A posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor, Cancer 95 (2002): 54-60.
    • (2002) Cancer , vol.95 , pp. 54-60
    • Litwin, M.S.1    Lubeck, D.P.2    Spitalny, G.M.3
  • 156
    • 0037108282 scopus 로고    scopus 로고
    • Defining sexual out comes after treatment for localized prostate cancinoma
    • L. R. Schover, R. T. Fouladi, C. L. Warneke, et al., Defining sexual out comes after treatment for localized prostate cancinoma, Cancer 95 (2002): 1773-85.
    • (2002) Cancer , vol.95 , pp. 1773-1785
    • Schover, L.R.1    Fouladi, R.T.2    Warneke, C.L.3
  • 157
    • 4344694747 scopus 로고    scopus 로고
    • Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer
    • B. K. Hollenbeck, R. L. Dunn, J. T. Wei, et al., Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer, Current Urology Reports 5 (2004): 212-219
    • (2004) Current Urology Reports , vol.5 , pp. 212-219
    • Hollenbeck, B.K.1    Dunn, R.L.2    Wei, J.T.3
  • 158
    • 0037405504 scopus 로고    scopus 로고
    • Health related quality of life in men with pros tate cancer
    • D. F. Penson, M. S. Litwin, and N. K. Aaronson, Health related quality of life in men with pros tate cancer, Journal of Urology 169 (2003): 1653-61
    • (2003) Journal of Urology , vol.169 , pp. 1653-1661
    • Penson, D.F.1    Litwin, M.S.2    Aaronson, N.K.3
  • 159
    • 0033975090 scopus 로고    scopus 로고
    • Quality of life outcomes after brachytherapy for early stage prostate cancer
    • J. M. Brandeis, M. S. Litwin, C. M. Burnison, et al., Quality of life outcomes after brachytherapy for early stage prostate cancer, Journal of Urology 163 (2000): 851-857;
    • (2000) Journal of Urology , vol.163 , pp. 851-857
    • Brandeis, J.M.1    Litwin, M.S.2    Burnison, C.M.3
  • 160
    • 8144227713 scopus 로고    scopus 로고
    • Permanent 125i-seed brachytherapy or radical prostatectomy: A prospective comparison considering oncological and quality of life results
    • J. M. Brandeis, M. S. Litwin, C. M. Burnison, et al., Permanent 125I-seed brachytherapy or radical prostatectomy: A prospective comparison considering oncological and quality of life results, BJU International 94 (2004): 805-811.
    • (2004) BJU International , vol.94 , pp. 805-811
    • Brandeis, J.M.1    Litwin, M.S.2    Burnison, C.M.3
  • 161
    • 4644287961 scopus 로고    scopus 로고
    • Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
    • A. L. Potosky, W. W. Davis, R. M. Hoffman, et al., Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The Prostate Cancer Outcomes Study, Journal of the National Cancer Institute 96 (2004): 1358-67.
    • (2004) Journal of the National Cancer Institute , vol.96 , pp. 1358-1367
    • Potosky, A.L.1    Davis, W.W.2    Hoffman, R.M.3
  • 162
    • 9644265229 scopus 로고    scopus 로고
    • Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer
    • E. B. Bradley, E. A. Bissonette, and D. Theodorescu, Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer, BJU In ternational 94 (2004): 1003-9;
    • (2004) BJU in Ternational , vol.94 , pp. 1003-1009
    • Bradley, E.B.1    Bissonette, E.A.2    Theodorescu, D.3
  • 163
    • 0037080315 scopus 로고    scopus 로고
    • Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer
    • J. T. Wei, R. L. Dunn, H. M. Sandler, et al., Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer, Journal of Clinical Oncology 20 (2002): 557-566.
    • (2002) Journal of Clinical Oncology , vol.20 , pp. 557-566
    • Wei, J.T.1    Dunn, R.L.2    Sandler, H.M.3
  • 165
    • 0033957919 scopus 로고    scopus 로고
    • Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
    • P. C. Walsh, P. Marschke, D. Ricker, et al., Patient-reported urinary continence and sexual function after anatomic radical prostatectomy, Urology 55 (2000): 58-61;
    • (2000) Urology , vol.55 , pp. 58-61
    • Walsh, P.C.1    Marschke, P.2    Ricker, D.3
  • 166
    • 0028828097 scopus 로고
    • Effect of radical prostatec tomy for prostate cancer on patient quality of life: Results from a medicare survey
    • P. C. Walsh, P. Marschke, D. Ricker, et al., Effect of radical prostatec tomy for prostate cancer on patient quality of life: Results from a Medicare survey, Urology 45 (1995): 1007-15.
    • (1995) Urology , vol.45 , pp. 1007-1015
    • Walsh, P.C.1    Marschke, P.2    Ricker, D.3
  • 167
    • 0031972670 scopus 로고    scopus 로고
    • Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
    • J. A. Talcott, P. Rieker, J. A. Clark, et al., Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study, Journal of Clinical Oncology 16 (1998): 275-283
    • (1998) Journal of Clinical Oncology , vol.16 , pp. 275-283
    • Talcott, J.A.1    Rieker, P.2    Clark, J.A.3
  • 168
    • 0033762947 scopus 로고    scopus 로고
    • Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal multivariate quality of life analysis from the cancer of the prostate strategic urologic research endeavor
    • M. S. Litwin, D. J. Pasta, J. Yu, et al., Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor, Journal of Urology 164 (2000): 1973-77.
    • (2000) Journal of Urology , vol.164 , pp. 1973-1977
    • Litwin, M.S.1    Pasta, D.J.2    Yu, J.3
  • 169
    • 3142653152 scopus 로고    scopus 로고
    • Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from capsure
    • M. S. Litwin, N. Sadetsky, D. J. Pasta, et al., Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE, Journal of Urology 172 (2004): 515-519.
    • (2004) Journal of Urology , vol.172 , pp. 515-519
    • Litwin, M.S.1    Sadetsky, N.2    Pasta, D.J.3
  • 172
    • 18744368185 scopus 로고    scopus 로고
    • Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters
    • F. J. Bianco Jr., E. R. Riedel, C. B. Begg, et al., Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters, Journal of Urology 173 (2005): 2099-2103;
    • (2005) Journal of Urology , vol.173 , pp. 2099-2103
    • Bianco Jr., F.J.1    Riedel, E.R.2    Begg, C.B.3
  • 173
    • 4143053657 scopus 로고    scopus 로고
    • Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
    • K. A. Roehl, M. Han, C. G. Ramos, et al., Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results, Journal of Urology 172 (2004): 910-914;
    • (2004) Journal of Urology , vol.172 , pp. 910-914
    • Roehl, K.A.1    Han, M.2    Ramos, C.G.3
  • 174
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival
    • M. Han, A. W. Partin, C. R. Pound, et al., Long-term biochemical disease-free and cancer-specific survival, Urologic Clinics of North America 28 (2001): 555-565.
    • (2001) Urologic Clinics of North America , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3
  • 175
    • 0036141891 scopus 로고    scopus 로고
    • Cancer control with radical prostatectomy alone in 1,000 consecutive patients
    • G. W. Hull, F. Rabbani, F. Abbas, et al., Cancer control with radical prostatectomy alone in 1,000 consecutive patients, Journal of Urology 167 (2002): 528-534.
    • (2002) Journal of Urology , vol.167 , pp. 528-534
    • Hull, G.W.1    Rabbani, F.2    Abbas, F.3
  • 176
    • 0034667588 scopus 로고    scopus 로고
    • A nationwide charge comparison of the principal treatments for early stage prostate carcinoma
    • J. Brandeis, C. L. Pashos, J. M. Henning, et al., A nationwide charge comparison of the principal treatments for early stage prostate carcinoma, Cancer 89 (2000): 1792-99.
    • (2000) Cancer , vol.89 , pp. 1792-1799
    • Brandeis, J.1    Pashos, C.L.2    Henning, J.M.3
  • 177
    • 0036035109 scopus 로고    scopus 로고
    • The economic costs of early stage prostate cancer
    • C. S. Saigal and M. S. Litwin, The economic costs of early stage prostate cancer, Pharmacoeconomics 20 (2002): 869-878.
    • (2002) Pharmacoeconomics , vol.20 , pp. 869-878
    • Saigal, C.S.1    Litwin, M.S.2
  • 181
    • 0040272450 scopus 로고
    • New York: Simon and Schuster
    • Cornelius Ryan and Kathryn Morgan Ryan, A Private Battle (New York: Simon and Schuster, 1979), 20
    • (1979) A Private Battle , pp. 20
    • Ryan, C.1    Ryan, K.M.2
  • 184
    • 60749087551 scopus 로고    scopus 로고
    • Houston: Winedale Publishing
    • Desiree Howe, His Prostate and Me (Houston: Winedale Publishing, 2002), 104.
    • (2002) His Prostate and Me , pp. 104
    • Howe, D.1
  • 187
    • 84902929335 scopus 로고    scopus 로고
    • What part do spouses and partners play?
    • in Peter D. Grimm, John C. Blasko, and John E. Sylvester (eds.), New York: McGraw Hill
    • Jeff M. Michalski and John E. Sylvester, What part do spouses and partners play?, in Peter D. Grimm, John C. Blasko, and John E. Sylvester (eds.), The Prostate Cancer Treatment Book (New York: McGraw Hill, 2004), 61.
    • (2004) The Prostate Cancer Treatment Book , pp. 61
    • Michalski, J.M.1    Sylvester, J.E.2
  • 188
    • 84902931856 scopus 로고    scopus 로고
    • Treated for illness, then lost in labyrinth of bills
    • October 13
    • Katie Hafner, Treated for illness, then lost in labyrinth of bills, New York Times, October 13, 2005.
    • (2005) New York Times
    • Hafner, K.1
  • 189
    • 0029853725 scopus 로고    scopus 로고
    • Marriage and mortality in prostate cancer
    • A. Krongard, H. Lai, M. A. Burke, et al., Marriage and mortality in prostate cancer, Journal of Urology 156 (1996): 1696-1700.
    • (1996) Journal of Urology , vol.156 , pp. 1696-1700
    • Krongard, A.1    Lai, H.2    Burke, M.A.3
  • 190
    • 0036585041 scopus 로고    scopus 로고
    • Couples' experi ences with prostate cancer: Focus group research
    • J. Harden, A. Schafenacker, L. Northouse, et al., Couples' experi ences with prostate cancer: Focus group research, Oncology Nursing Forum 29 (2002): 701-709
    • (2002) Oncology Nursing Forum , vol.29 , pp. 701-709
    • Harden, J.1    Schafenacker, A.2    Northouse, L.3
  • 192
    • 1942467444 scopus 로고    scopus 로고
    • Preferences of husbands and wives for outcome of prostate cancer screening and treatment
    • R. J. Volk, S. B. Cantor, A. R. Cass, et al., Preferences of husbands and wives for outcome of prostate cancer screening and treatment, Journal of General Internal Medicine 19 (2004): 339-348.
    • (2004) Journal of General Internal Medicine , vol.19 , pp. 339-348
    • Volk, R.J.1    Cantor, S.B.2    Cass, A.R.3
  • 193
    • 18444368413 scopus 로고    scopus 로고
    • Gaymen and prostate cancer: Invisible diversity
    • T. O. Blank, Gaymen and prostate cancer: Invisible diversity, Journal of Clinical Oncology 23 (2005): 2593-96.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 2593-2596
    • Blank, T.O.1
  • 203
    • 0037376436 scopus 로고    scopus 로고
    • Sexual function after radical prostatectomy (editorial)
    • J. A. Smith Jr., Sexual function after radical prostatectomy (editorial), Journal of Urology 169 (2003): 1465.
    • (2003) Journal of Urology , vol.169 , pp. 1465
    • Smith Jr., J.A.1
  • 209
    • 84902930774 scopus 로고    scopus 로고
    • Treatment for urinary incontinence among prostate cancer surgery patients
    • October 19
    • Treatment for urinary incontinence among prostate cancer surgery patients, Medical News Today, October 19, 2004.
    • (2004) Medical News Today
  • 210
    • 22344442113 scopus 로고    scopus 로고
    • Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms
    • S. Namiki, S. Saito, S. Ishidoya, et al., Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms, Urology 66 (2005): 147-151.
    • (2005) Urology , vol.66 , pp. 147-151
    • Namiki, S.1    Saito, S.2    Ishidoya, S.3
  • 211
    • 84902944205 scopus 로고
    • New York: Cadell and Davies
    • William Martin, My Prostate and Me (New York: Cadell and Davies, 1994), 125-127
    • (1994) My Prostate and Me , pp. 125-127
    • Martin, W.1
  • 216
    • 84902924162 scopus 로고    scopus 로고
    • Male orgasmic quality affected by prostate cancer surgery
    • May 9
    • Male orgasmic quality affected by prostate cancer surgery, Medical News Today, May 9, 2004
    • (2004) Medical News Today
  • 220
    • 20244372712 scopus 로고    scopus 로고
    • 5-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer out comes study
    • D. F. Penson, D. McLerran, Z. Feng, et al., 5-Year urinary and sexual outcomes after radical prostatectomy: Results from the Prostate Cancer Out comes Study, Journal of Urology 173 (2005): 1701-5;
    • (2005) Journal of Urology , vol.173 , pp. 1701-1705
    • Penson, D.F.1    McLerran, D.2    Feng, Z.3
  • 221
    • 22144441746 scopus 로고    scopus 로고
    • Men in australia telephone survey (mates): A national survey of the reproductive health and concerns of middle-aged and older australian men
    • C. A. Holden, R. I. McLachlan, M. Pitts, et al., Men in Australia Telephone Survey (MATeS): A national survey of the reproductive health and concerns of middle-aged and older Australian men, Lancet 366 (2005): 218-224.
    • (2005) Lancet , vol.366 , pp. 218-224
    • Holden, C.A.1    McLachlan, R.I.2    Pitts, M.3
  • 222
    • 23744452466 scopus 로고    scopus 로고
    • Health-related quality of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 era: Impact of neurovascular bundle preservation
    • M. C. Haffner, P. K. Landis, C. S. Saigal, et al., Health-related quality of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 era: Impact of neurovascular bundle preservation, Urology 66 (2005): 371-376.
    • (2005) Urology , vol.66 , pp. 371-376
    • Haffner, M.C.1    Landis, P.K.2    Saigal, C.S.3
  • 223
    • 0034799317 scopus 로고    scopus 로고
    • Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction"
    • B. G. Bokhour, J. A. Clark, T. S. Inui, et al., Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction," Journal of General Internal Medicine 16 (2001): 649-655.
    • (2001) Journal of General Internal Medicine , vol.16 , pp. 649-655
    • Bokhour, B.G.1    Clark, J.A.2    Inui, T.S.3
  • 228
    • 85047657662 scopus 로고    scopus 로고
    • Viagra and loss of vision
    • Viagra and loss of vision, Medical Letter 47 (2005): 49
    • (2005) Medical Letter , vol.47 , pp. 49
  • 229
    • 23944435538 scopus 로고    scopus 로고
    • Association of combined nonarteritic anterior ischemic optic neuropathy (naion) and obstruction of cilioretinal artery with overdose of viagra
    • R. Akash, D. Hrishikesh, P. Amith, et al., Association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra, Journal of Ocular Pharmacology and Therpeutics 21 (2005): 315-317.
    • (2005) Journal of Ocular Pharmacology and Therpeutics , vol.21 , pp. 315-317
    • Akash, R.1    Hrishikesh, D.2    Amith, P.3
  • 230
    • 0347129566 scopus 로고    scopus 로고
    • Sildenafil preserves intra corporeal smooth muscle after radical retropubic prostatectomy
    • E. J. Schwartz, P. Wong, and R. J. Graydon, Sildenafil preserves intra corporeal smooth muscle after radical retropubic prostatectomy, Journal of Urology 171 (2004): 771-774.
    • (2004) Journal of Urology , vol.171 , pp. 771-774
    • Schwartz, E.J.1    Wong, P.2    Graydon, R.J.3
  • 232
    • 19644377177 scopus 로고    scopus 로고
    • Erectile dysfunction following radical prostatectomy
    • A. L. Burnett, Erectile dysfunction following radical prostatectomy, Journal of the American Medical Association 293 (2005): 2648-53.
    • (2005) Journal of the American Medical Association , vol.293 , pp. 2648-2653
    • Burnett, A.L.1
  • 234
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival
    • M. Han, A. W. Partin, C. R. Pound, et al., Long-term biochemical disease-free and cancer-specific survival, Urologic Clinics of North America 28 (2001): 555-565
    • (2001) Urologic Clinics of North America , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3
  • 235
    • 7444270534 scopus 로고    scopus 로고
    • Pre operative psa level significantly associated with interval to biochemical progression after radical retropubic prostatectomy
    • C. M. Gonzalez, K. A. Roehl, J. A. V. Antenor, et al., Pre operative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy, Urology 64 (2004): 723-728;
    • (2004) Urology , vol.64 , pp. 723-728
    • Gonzalez, C.M.1    Roehl, K.A.2    Antenor, J.A.V.3
  • 236
    • 0242412469 scopus 로고    scopus 로고
    • Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer
    • M. A. Khan, A. W. Partin, L. A. Mangold, et al., Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer, Urology 62 (2003): 866-871
    • (2003) Urology , vol.62 , pp. 866-871
    • Khan, M.A.1    Partin, A.W.2    Mangold, L.A.3
  • 237
    • 3242755103 scopus 로고    scopus 로고
    • Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer
    • C. G. Ramos, K. A. Roehl, J. A. V. Antenor, et al., Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer, Journal of Urology 172 (2004): 137-140.
    • (2004) Journal of Urology , vol.172 , pp. 137-140
    • Ramos, C.G.1    Roehl, K.A.2    Antenor, J.A.V.3
  • 238
    • 0034747687 scopus 로고    scopus 로고
    • Use of gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy
    • M. L. Blute, E. J. Bergstralh, A. Iocca, et al., Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy, Journal of Urology 165 (2001): 119-125.
    • (2001) Journal of Urology , vol.165 , pp. 119-125
    • Blute, M.L.1    Bergstralh, E.J.2    Iocca, A.3
  • 239
    • 0032950295 scopus 로고    scopus 로고
    • Postoperative nomo gram for disease recurrence after radical prostatectomy for prostate cancer
    • M. W. Kattan, T. M. Wheeler, and P. T. Scardino, Postoperative nomo gram for disease recurrence after radical prostatectomy for prostate cancer, Journal of Clinical Oncology 17 (1999): 1499-1507.
    • (1999) Journal of Clinical Oncology , vol.17 , pp. 1499-1507
    • Kattan, M.W.1    Wheeler, T.M.2    Scardino, P.T.3
  • 241
    • 22844434877 scopus 로고    scopus 로고
    • Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    • S. J. Freed land, E. B. Humphreys, L. A. Mangold, et al., Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy, Journal of the American Medical Association 294 (2005): 433-439.
    • (2005) Journal of the American Medical Association , vol.294 , pp. 433-439
    • Freed land, S.J.1    Humphreys, E.B.2    Mangold, L.A.3
  • 243
  • 244
    • 0033526345 scopus 로고    scopus 로고
    • Management of prostate cancer after prostatectomy: Treating the patient, not the psa [editorial]
    • H. I. Scher, Management of prostate cancer after prostatectomy: Treating the patient, not the PSA [editorial], Journal of the American Medical Association 281 (1999): 1642-45.
    • (1999) Journal of the American Medical Association , vol.281 , pp. 1642-1645
    • Scher, H.I.1
  • 245
    • 2442495089 scopus 로고    scopus 로고
    • Long-term followup of metastatic prostate cancer
    • J. Holzbeierlein, R. Payne, J. Weigel, et al., Long-term followup of metastatic prostate cancer, Journal of Urology 171 (2004): 2377.
    • (2004) Journal of Urology , vol.171 , pp. 2377
    • Holzbeierlein, J.1    Payne, R.2    Weigel, J.3
  • 246
    • 0036296523 scopus 로고    scopus 로고
    • Clinical predic tors of androgen-independent prostate cancer and survival in the prostatespecific antigen era
    • M. G. Oefelein, V. S. Ricchiuti, P. W. Conrad, et al., Clinical predic tors of androgen-independent prostate cancer and survival in the prostatespecific antigen era, Urology 60 (2002): 120-124.
    • (2002) Urology , vol.60 , pp. 120-124
    • Oefelein, M.G.1    Ricchiuti, V.S.2    Conrad, P.W.3
  • 247
    • 0031403675 scopus 로고    scopus 로고
    • Medical research council trial
    • Medical Research Council trial, British Journal of Urology 79 (1997): 235-246
    • (1997) British Journal of Urology , vol.79 , pp. 235-246
  • 248
    • 0033540004 scopus 로고    scopus 로고
    • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
    • E. M. Messing, J. Manola, M. Sarosdy, et al., Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer, New England Journal of Medicine 341 (1999): 1781-88.
    • (1999) New England Journal of Medicine , vol.341 , pp. 1781-1788
    • Messing, E.M.1    Manola, J.2    Sarosdy, M.3
  • 250
    • 12444317207 scopus 로고    scopus 로고
    • Intermittent versus continu ous total androgen blockade in the treatment of patients with advanced hormone-naïve prostate cancer: Results of a prospective randomized multi centertrial
    • J. de Leval, P. Boca, E. Youssef, et al., Intermittent versus continu ous total androgen blockade in the treatment of patients with advanced hormone-naïve prostate cancer: Results of a prospective randomized multi centertrial, Clinical Prostate Cancer 1 (2002): 163-171
    • (2002) Clinical Prostate Cancer , vol.1 , pp. 163-171
    • de Leval, J.1    Boca, P.2    Youssef, E.3
  • 251
    • 1542673411 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer
    • E. Youssef, S. Tekyi Mensah, K. Hart, et al., Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer, American Journal of Clinical Oncology 26 (2003): e119-e123.
    • (2003) American Journal of Clinical Oncology , vol.26
    • Youssef, E.1    Mensah, S.T.2    Hart, K.3
  • 252
    • 8344272906 scopus 로고    scopus 로고
    • Long-term out comes in patients with prostate cancer managed with intermittent androgen suppression
    • T. M. Lane, W. Ansell, D. Farrugia, et al., Long-term out comes in patients with prostate cancer managed with intermittent androgen suppression, Urologia Internationalis 73 (2004): 117-122
    • (2004) Urologia Internationalis , vol.73 , pp. 117-122
    • Lane, T.M.1    Ansell, W.2    Farrugia, D.3
  • 253
    • 1842840803 scopus 로고    scopus 로고
    • Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer
    • B. Hellerstedt, Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer, Urology 62 (2003) (suppl. 6B): 79-86.
    • (2003) Urology , vol.62 , Issue.SUPPL. 6B , pp. 79-86
    • Hellerstedt, B.1
  • 255
    • 0141954180 scopus 로고    scopus 로고
    • Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy
    • O. K. MacDonald, S. E. Schild, S. A. Vora, et al., Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy, Journal of Urology 170 (2003): 1833-37.
    • (2003) Journal of Urology , vol.170 , pp. 1833-1837
    • Macdonald, O.K.1    Schild, S.E.2    Vora, S.A.3
  • 256
    • 4744337716 scopus 로고    scopus 로고
    • Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
    • D. P. Petrylak, C. M. Tangen, M. H. A. Hussain, et al., Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer, New England Journal of Medicine 351 (2004): 1513-20
    • (2004) New England Journal of Medicine , vol.351 , pp. 1513-1520
    • Petrylak, D.P.1    Tangen, C.M.2    Hussain, M.H.A.3
  • 257
    • 4744366279 scopus 로고    scopus 로고
    • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
    • I. F. Tannock, R. de Wit, W. R. Berry, et al., Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer, New England Journal of Medicine 351 (2004): 1502-12.
    • (2004) New England Journal of Medicine , vol.351 , pp. 1502-1512
    • Tannock, I.F.1    de Wit, R.2    Berry, W.R.3
  • 258
    • 1842862675 scopus 로고    scopus 로고
    • Novel approaches to treat asymp tomatic, hormone-naïve patients with rising prostate-specific antigen after primary treatment for prostate cancer
    • N. A. Dawson and S. F. Slovin, Novel approaches to treat asymp tomatic, hormone-naïve patients with rising prostate-specific antigen after primary treatment for prostate cancer, Urology 62 (2003) (suppl. 6B): 102-118.
    • (2003) Urology , vol.62 , Issue.SUPPL. 6B , pp. 102-118
    • Dawson, N.A.1    Slovin, S.F.2
  • 259
    • 0038678123 scopus 로고    scopus 로고
    • High-risk localized prostate cancer: Primary surgery and adjuvant therapy
    • E. C. Skinner and L. M. Glode, High-risk localized prostate cancer: Primary surgery and adjuvant therapy, Urologic Oncology 21 (2003): 219-227.
    • (2003) Urologic Oncology , vol.21 , pp. 219-227
    • Skinner, E.C.1    Glode, L.M.2
  • 260
    • 0035131315 scopus 로고    scopus 로고
    • Quality of life before death for men with prostate cancer: Results from the capsure data base
    • M. S. Litwin, D. P. Lubeck, M. L. Stoddard, et al., Quality of life before death for men with prostate cancer: Results from the CaPSURE data base, Journal of Urology 165 (2001): 871-875
    • (2001) Journal of Urology , vol.165 , pp. 871-875
    • Litwin, M.S.1    Lubeck, D.P.2    Stoddard, M.L.3
  • 261
    • 1942501724 scopus 로고    scopus 로고
    • A population-based study of pain and quality of life during the year before death in men with prostate cancer
    • G. Sandblom, P. Carlsson, K. Sennfält, et al., A population-based study of pain and quality of life during the year before death in men with prostate cancer, British Journal of Cancer 90 (2004): 1163-68.
    • (2004) British Journal of Cancer , vol.90 , pp. 1163-1168
    • Sandblom, G.1    Carlsson, P.2    Sennfält, K.3
  • 262
    • 0036141290 scopus 로고    scopus 로고
    • Quality of life at the end of life: Trends in patients with metastatic prostate cancer
    • G. Y. Melmed, L. Kwan, K. Reid, et al., Quality of life at the end of life: Trends in patients with metastatic prostate cancer, Urology 59 (2002): 103-109.
    • (2002) Urology , vol.59 , pp. 103-109
    • Melmed, G.Y.1    Kwan, L.2    Reid, K.3
  • 264
    • 0040272450 scopus 로고
    • New York: Simon and Schuster
    • Cornelius Ryan and Kathryn Morgan Ryan, A Private Battle (New York: Simon and Schuster, 1979), 208.
    • (1979) A Private Battle , pp. 208
    • Ryan, C.1    Ryan, K.M.2
  • 267
    • 0027244510 scopus 로고
    • The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
    • W. A. Sakr, G. P. Haas, B. F. Cassin, et al., The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients, Journal of Urology 150 (1993): 379-385.
    • (1993) Journal of Urology , vol.150 , pp. 379-385
    • Sakr, W.A.1    Haas, G.P.2    Cassin, B.F.3
  • 268
    • 23744512048 scopus 로고    scopus 로고
    • Prostate specific antigen levels in young adulthood predict prostate cancer risk: Results from a cohort of black and white americans
    • A. S. Whittemore, P. M. Cirillo, D. Feldman, et al., Prostate specific antigen levels in young adulthood predict prostate cancer risk: Results from a cohort of black and white Americans, Journal of Urology 174 (2005): 872-876.
    • (2005) Journal of Urology , vol.174 , pp. 872-876
    • Whittemore, A.S.1    Cirillo, P.M.2    Feldman, D.3
  • 269
    • 0033991685 scopus 로고    scopus 로고
    • International trends and patterns of prostate cancer incidence and mortality
    • A. W. Hsing, L. Tsao, and S. S. Devesa, International trends and patterns of prostate cancer incidence and mortality, International Journal of Cancer 85 (2000): 60-67.
    • (2000) International Journal of Cancer , vol.85 , pp. 60-67
    • Hsing, A.W.1    Tsao, L.2    Devesa, S.S.3
  • 271
    • 0042236664 scopus 로고    scopus 로고
    • Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer
    • K. E. Gaston, D. Kim, S. Singh, et al., Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer, Journal of Urology 170 (2003): 990-993.
    • (2003) Journal of Urology , vol.170 , pp. 990-993
    • Gaston, K.E.1    Kim, D.2    Singh, S.3
  • 272
  • 273
    • 0027466886 scopus 로고
    • Stage at presentation and survival of white and black patients with prostate carcinoma
    • P. N. Brawn, E. H. Johnson, D. L. Kuhl, et al., Stage at presentation and survival of white and black patients with prostate carcinoma, Cancer 71 (1993): 2569-73
    • (1993) Cancer , vol.71 , pp. 2569-2573
    • Brawn, P.N.1    Johnson, E.H.2    Kuhl, D.L.3
  • 275
    • 73649150006 scopus 로고
    • Malignant neoplasms among alaskan natives: An epidemiological approach to cancer
    • E. F. Torrey, Malignant neoplasms among Alaskan natives: An epidemiological approach to cancer, McGill Medical Journal 31 (1962): 107-115
    • (1962) McGill Medical Journal , vol.31 , pp. 107-115
    • Torrey, E.F.1
  • 276
    • 0035408002 scopus 로고    scopus 로고
    • Cancer mortality among alaska natives, 1994-1998
    • G. Ehrsam, A. Lanier, P. Holck, et al., Cancer mortality among Alaska natives, 1994-1998, Alaska Medicine 43 (2001): 50-60
    • (2001) Alaska Medicine , vol.43 , pp. 50-60
    • Ehrsam, G.1    Lanier, A.2    Holck, P.3
  • 277
    • 0041846688 scopus 로고    scopus 로고
    • Cancer mortality among American Indians and Alaska natives-United States, 1994-1998
    • Cancer mortality among American Indians and Alaska natives-United States, 1994-1998, Morbidity and Mortality Weekly Reports 52 (2003): 704-707
    • (2003) Morbidity and Mortality Weekly Reports , vol.52 , pp. 704-707
  • 278
    • 0141675013 scopus 로고    scopus 로고
    • Inuit are protected against prostate cancer, cancer epidemiology
    • E. Dewailly, G. Mulvad, H. S. Pedersen, et al., Inuit are protected against prostate cancer, Cancer Epidemiology, Biomarkers, and Prevention 12 (2003): 926-927
    • (2003) Biomarkers, and Prevention , vol.12 , pp. 926-927
    • Dewailly, E.1    Mulvad, G.2    Pedersen, H.S.3
  • 279
    • 3242676093 scopus 로고    scopus 로고
    • Patterns in cancer incidence among American Indians/Alaska natives, United States, 1992-1999
    • D. N. Paltoo and K. C. Chu, Patterns in cancer incidence among American Indians/Alaska natives, United States, 1992-1999, Public Health Reports 119 (2004): 443-451
    • (2004) Public Health Reports , vol.119 , pp. 443-451
    • Paltoo, D.N.1    Chu, K.C.2
  • 280
  • 281
  • 282
    • 0029010968 scopus 로고
    • The geography of prostate cancer and its treatment in Africa
    • Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press
    • E. O. Kehinde, The geography of prostate cancer and its treatment in Africa, Cancer Surveys. Preventing Prostate Cancer: Screening versus Chemoprevention (Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1995), 281-286
    • (1995) Cancer Surveys. Preventing Prostate Cancer: Screening Versus Chemoprevention , pp. 281-286
    • Kehinde, E.O.1
  • 283
    • 0030940431 scopus 로고    scopus 로고
    • Prostate cancer in nigerians: Facts and non facts
    • D. N. Osegbe, Prostate cancer in Nigerians: Facts and non facts, Journal of Urology 157 (1997): 1340-43.
    • (1997) Journal of Urology , vol.157 , pp. 1340-1343
    • Osegbe, D.N.1
  • 284
    • 16344368667 scopus 로고    scopus 로고
    • Changing demography of prostate cancer in Asia
    • H. G. Sim and C. W. S. Cheng, Changing demography of prostate cancer in Asia, European Journal of Cancer 41 (2005): 834-845.
    • (2005) European Journal of Cancer , vol.41 , pp. 834-845
    • Sim, H.G.1    Cheng, C.W.S.2
  • 285
    • 0025769201 scopus 로고
    • Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county
    • H. Shimizu, R. K. Ross, L. Bernstein, et al., Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County, British Journal of Cancer 63 (1991): 963-966
    • (1991) British Journal of Cancer , vol.63 , pp. 963-966
    • Shimizu, H.1    Ross, R.K.2    Bernstein, L.3
  • 286
    • 0032846010 scopus 로고    scopus 로고
    • Incidence of adenocarcinoma of the prostate in asian immigrants to the united states and their descendants
    • L. S. Cook, M. Goldoft, S. M. Schwartz, et al., Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants, Journal of Urology 161 (1999): 152-155;
    • (1999) Journal of Urology , vol.161 , pp. 152-155
    • Cook, L.S.1    Goldoft, M.2    Schwartz, S.M.3
  • 289
    • 18844381612 scopus 로고    scopus 로고
    • Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993
    • S. O. Dalton, L. Mellemkjaer, L. Thomassen, et al., Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993, Schizophrenia Research 75 (2005): 315-324
    • (2005) Schizophrenia Research , vol.75 , pp. 315-324
    • Dalton, S.O.1    Mellemkjaer, L.2    Thomassen, L.3
  • 291
    • 0026522893 scopus 로고
    • Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients
    • P. B. Mortensen, Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients, Acta Psychiatrica Scandinavica 85 (1992): 390-393.
    • (1992) Acta Psychiatrica Scandinavica , vol.85 , pp. 390-393
    • Mortensen, P.B.1
  • 292
    • 0027202421 scopus 로고
    • Hereditary prostate cancer: Epidemiologic and clinical features
    • B. S. Carter, G. S. Bova, T. H. Beaty, et al., Hereditary prostate cancer: Epidemiologic and clinical features, Journal of Urology 150 (1993): 797-802.
    • (1993) Journal of Urology , vol.150 , pp. 797-802
    • Carter, B.S.1    Bova, G.S.2    Beaty, T.H.3
  • 293
    • 84902942393 scopus 로고    scopus 로고
    • A bond of brothers
    • September 2
    • A Bond of Brothers, NEWSWISE Medical News, September 2, 2004.
    • (2004) NEWSWISE Medical News
  • 294
    • 0034644185 scopus 로고    scopus 로고
    • Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland
    • P. Lichtenstein, N. V. Holm, P. K. Verkasalo, et al., Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland, New England Journal of Medicine 343 (2000): 78-85.
    • (2000) New England Journal of Medicine , vol.343 , pp. 78-85
    • Lichtenstein, P.1    Holm, N.V.2    Verkasalo, P.K.3
  • 295
    • 1842612064 scopus 로고    scopus 로고
    • The complex genetic epidemiology of prostate cancer
    • D. J. Schaid, The complex genetic epidemiology of prostate cancer, Human Molecular Genetics 13 (2004): R103-R121
    • (2004) Human Molecular Genetics , vol.13
    • Schaid, D.J.1
  • 296
    • 0347915530 scopus 로고    scopus 로고
    • Association of brain tumours with other neoplasms in families
    • K. Hemminki and X. Li, Association of brain tumours with other neoplasms in families, European Journal of Cancer 40 (2004): 253-259.
    • (2004) European Journal of Cancer , vol.40 , pp. 253-259
    • Hemminki, K.1    Li, X.2
  • 297
    • 0346997972 scopus 로고    scopus 로고
    • Epidemiology of prostate cancer
    • E. D. Crawford, Epidemiology of prostate cancer, Journal of Urology 62 (suppl. 6A) (2003): 3-12.
    • (2003) Journal of Urology , vol.62 , Issue.SUPPL. 6A , pp. 3-12
    • Crawford, E.D.1
  • 298
    • 0015722008 scopus 로고
    • Herpesvirus particles in prostatic carcinoma cells
    • Y. M. Centifanto, H. E. Kaufman, Z. S. Zam, et al., Herpesvirus particles in prostatic carcinoma cells, Journal of Virology 12 (1973): 1608-11.
    • (1973) Journal of Virology , vol.12 , pp. 1608-1611
    • Centifanto, Y.M.1    Kaufman, H.E.2    Zam, Z.S.3
  • 299
    • 0042236661 scopus 로고    scopus 로고
    • High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carci noma
    • M. Samanta, L. Harkins, K. Klemm, et al., High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carci noma, Journal of Urology 170 (2003): 998-1002
    • (2003) Journal of Urology , vol.170 , pp. 998-1002
    • Samanta, M.1    Harkins, L.2    Klemm, K.3
  • 300
    • 0037319449 scopus 로고    scopus 로고
    • Herpes simplex virus, cytomegalovirus, and papillo mavirus dna are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer
    • M. J. Leskinen, R. Vainionpaa, S. Syrjanen, et al., Herpes simplex virus, cytomegalovirus, and papillo mavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer, Urology 61 (2003): 397-401
    • (2003) Urology , vol.61 , pp. 397-401
    • Leskinen, M.J.1    Vainionpaa, R.2    Syrjanen, S.3
  • 301
    • 0036733757 scopus 로고    scopus 로고
    • Demonstra tion of epstein-barr virus in carcinomas of various sites
    • S. Grinstein, M. V. Preciado, P. Gattuso, et al., Demonstra tion of Epstein-Barr virus in carcinomas of various sites, Cancer Research 62 (2002): 4876-78;
    • (2002) Cancer Research , vol.62 , pp. 4876-4878
    • Grinstein, S.1    Preciado, M.V.2    Gattuso, P.3
  • 302
    • 1642498279 scopus 로고    scopus 로고
    • Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer
    • L. J. Hoffman, C. H. Bunker, P. E. Pellett, et al., Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer, Journal of Infectious Diseases 189 (2004): 15-20
    • (2004) Journal of Infectious Diseases , vol.189 , pp. 15-20
    • Hoffman, L.J.1    Bunker, C.H.2    Pellett, P.E.3
  • 303
    • 0037663943 scopus 로고    scopus 로고
    • Detecting the expression of human endogenous retroviruse envelope transcripts in human prostate adenocarcinoma
    • F. Wang-Johanning, A. R. Frost, B. Jian, et al., Detecting the expression of human endogenous retroviruse envelope transcripts in human prostate adenocarcinoma, Cancer 98 (2003): 187-197
    • (2003) Cancer , vol.98 , pp. 187-197
    • Wang-Johanning, F.1    Frost, A.R.2    Jian, B.3
  • 304
    • 0036892208 scopus 로고    scopus 로고
    • Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections
    • A. Zambrano, M. Kalantari, and A. Simoneau, Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections, Prostate 53 (2002): 263-276.
    • (2002) Prostate , vol.53 , pp. 263-276
    • Zambrano, A.1    Kalantari, M.2    Simoneau, A.3
  • 305
    • 0032520768 scopus 로고    scopus 로고
    • A multifaceted study of hu man papillomavirus and prostate carcinoma
    • H. D. Strickler, R. Burk, K. Shah, et al., A multifaceted study of hu man papillomavirus and prostate carcinoma, Cancer 82 (1998): 1118-25
    • (1998) Cancer , vol.82 , pp. 1118-1125
    • Strickler, H.D.1    Burk, R.2    Shah, K.3
  • 306
    • 0141452078 scopus 로고    scopus 로고
    • Prostate cancer risk and serologic evidence of human papilloma virus infection: A population-based casecontrol study, cancer epidemiology
    • H. D. Strickler, R. Burk, K. Shah, et al., Prostate cancer risk and serologic evidence of human papilloma virus infection: A population-based casecontrol study, Cancer Epidemiology, Biomarkers, and Prevention 12 (2003): 872-875.
    • (2003) Biomarkers, and Prevention , vol.12 , pp. 872-875
    • Strickler, H.D.1    Burk, R.2    Shah, K.3
  • 309
    • 0036136142 scopus 로고    scopus 로고
    • Meta-analysis of measures of sexual activity and prostate cancer
    • L. K. Dennis and D. V. Dawson, Meta-analysis of measures of sexual activity and prostate cancer, Epidemiology 13 (2002): 72-79;
    • (2002) Epidemiology , vol.13 , pp. 72-79
    • Dennis, L.K.1    Dawson, D.V.2
  • 310
    • 20044369150 scopus 로고    scopus 로고
    • Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: A case-control study in cuba
    • L. Fernandez, Y. Galán, R. Jiménez, et al., Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: A case-control study in Cuba, Inter national Journal of Epidemiology 34 (2005): 193-197
    • (2005) Inter National Journal of Epidemiology , vol.34 , pp. 193-197
    • Fernandez, L.1    Galán, Y.2    Jiménez, R.3
  • 311
    • 4544291998 scopus 로고    scopus 로고
    • Medical history, sexual, and maturational factors and prostate cancer risk
    • N. Lightfoot, M. Con lon, N. Kreiger, et al., Medical history, sexual, and maturational factors and prostate cancer risk, Annals of Epidemiology 14 (2004): 655-662
    • (2004) Annals of Epidemiology , vol.14 , pp. 655-662
    • Lightfoot, N.1    Conlon, M.2    Kreiger, N.3
  • 313
    • 22044443626 scopus 로고    scopus 로고
    • Prostate cancer and sexually transmitted diseases: A meta-analysis
    • M. L. Taylor, A. G. Mainous III, and B. J. Wells, Prostate cancer and sexually transmitted diseases: A meta-analysis, Family Medicine 37 (2005): 506-512.
    • (2005) Family Medicine , vol.37 , pp. 506-512
    • Taylor, M.L.1    Mainous III, A.G.2    Wells, B.J.3
  • 314
    • 31044442044 scopus 로고    scopus 로고
    • Prostate cancer and consistency of reporting sexual histories in men over age 50
    • L. K. Dennis, J. M. Ritchie, and M. I. Resnick, Prostate cancer and consistency of reporting sexual histories in men over age 50, Prostate Cancer and Prostatic Diseases 8 (2005): 243-247.
    • (2005) Prostate Cancer and Prostatic Diseases , vol.8 , pp. 243-247
    • Dennis, L.K.1    Ritchie, J.M.2    Resnick, M.I.3
  • 315
    • 0019427678 scopus 로고
    • A cohort study of mortality from cancer of the prostate in catholic priests
    • R. K. Ross, D. M. Deapen, J. T. Casagrande, et al., A cohort study of mortality from cancer of the prostate in Catholic priests, British Journal of Cancer 43 (1981): 233-235.
    • (1981) British Journal of Cancer , vol.43 , pp. 233-235
    • Ross, R.K.1    Deapen, D.M.2    Casagrande, J.T.3
  • 316
    • 0034811710 scopus 로고    scopus 로고
    • Hormones and prostate cancer: What's next?
    • A. W. Hsing, Hormones and prostate cancer: What's next? Epidemio logic Reviews 23 (2001): 42-58
    • (2001) Epidemio Logic Reviews , vol.23 , pp. 42-58
    • Hsing, A.W.1
  • 317
    • 22144488457 scopus 로고    scopus 로고
    • Prostate cancer in men using testosterone supplementation
    • F. D. Gaylis, D. W. Lin, J. M. Ignatoff, et al., Prostate cancer in men using testosterone supplementation, Journal of Urology 174 (2005): 534-538
    • (2005) Journal of Urology , vol.174 , pp. 534-538
    • Gaylis, F.D.1    Lin, D.W.2    Ignatoff, J.M.3
  • 318
    • 1642458222 scopus 로고    scopus 로고
    • Risks of testosterone-replacement therapy and recommendations for monitoring
    • E. L. Rhoden and A. Morgentaler, Risks of testosterone-replacement therapy and recommendations for monitoring, New England Journal of Medicine 350 (2004): 482-492.
    • (2004) New England Journal of Medicine , vol.350 , pp. 482-492
    • Rhoden, E.L.1    Morgentaler, A.2
  • 319
    • 0026552456 scopus 로고
    • Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health
    • L. Ellis and H. Nyborg, Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health, Steroids 57 (1992): 72-75
    • (1992) Steroids , vol.57 , pp. 72-75
    • Ellis, L.1    Nyborg, H.2
  • 320
    • 0026553251 scopus 로고
    • 5-alpha-reductase activity and risk of prostate cancer among japanese and us white and black males
    • R. Ross, L. Bernstein, R. A. Lobo, et al., 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males, Lancet 339 (1992): 887-889
    • (1992) Lancet , vol.339 , pp. 887-889
    • Ross, R.1    Bernstein, L.2    Lobo, R.A.3
  • 321
    • 22244448960 scopus 로고    scopus 로고
    • Comparison of prostate-specific antigen and hormone levels among men in singapore and the united states, cancer epidemiology
    • I. Cheng, M. C. Yu, W.-P. Koh, et al., Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States, Cancer Epidemiology, Biomarkers, and Prevention 14 (2005): 1692-96.
    • (2005) Biomarkers, and Prevention , vol.14 , pp. 1692-1696
    • Cheng, I.1    Yu, M.C.2    Koh, W.-P.3
  • 323
    • 0016683880 scopus 로고
    • Environmental factors and cancer inci dence and mortality in different countries, with special reference to dietary practices
    • B. Armstrong and R. Doll, Environmental factors and cancer inci dence and mortality in different countries, with special reference to dietary practices, International Journal of Cancer 15 (1975): 617-631.
    • (1975) International Journal of Cancer , vol.15 , pp. 617-631
    • Armstrong, B.1    Doll, R.2
  • 324
    • 0642341273 scopus 로고    scopus 로고
    • Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 norwegianmen
    • M. B. Veierod, P. Laake, and D. S. Thelle, Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegianmen, Inter national Journal of Cancer 73 (1997): 634-638
    • (1997) Inter National Journal of Cancer , vol.73 , pp. 634-638
    • Veierod, M.B.1    Laake, P.2    Thelle, D.S.3
  • 328
    • 0032145690 scopus 로고    scopus 로고
    • The association between vasectomy and prostate cancer: A systematic review of the literature
    • L. K. Dennis and R. B. Hayes, The association between vasectomy and prostate cancer: A systematic review of the literature, Fertility and Sterility 70 (1998): 191-200.
    • (1998) Fertility and Sterility , vol.70 , pp. 191-200
    • Dennis, L.K.1    Hayes, R.B.2
  • 329
    • 1842739134 scopus 로고    scopus 로고
    • Association between agent orange and prostate cancer: A pilot case-control study
    • V. N. Giri, A. E. Cassidy, J. Beebe-Dimmer, et al., Association between Agent Orange and prostate cancer: A pilot case-control study, Journal of Urology 63 (2004): 757-761.
    • (2004) Journal of Urology , vol.63 , pp. 757-761
    • Giri, V.N.1    Cassidy, A.E.2    Beebe-Dimmer, J.3
  • 331
    • 0037029080 scopus 로고    scopus 로고
    • A prospective study of tomato products, lycopene, and prostate cancer risk
    • E. Giovannucci, E. B. Rimm, Y. Liu, et al., A prospective study of tomato products, lycopene, and prostate cancer risk, Journal of the National Cancer Institute 94 (2002): 391-398
    • (2002) Journal of the National Cancer Institute , vol.94 , pp. 391-398
    • Giovannucci, E.1    Rimm, E.B.2    Liu, Y.3
  • 332
    • 0038262034 scopus 로고    scopus 로고
    • Can the consumption of tomatoes or lycopene reduce cancer risk?
    • E. Giovannucci, E. B. Rimm, Y. Liu, et al., Can the consumption of tomatoes or lycopene reduce cancer risk? Integrative Cancer Therapies 1 (2002): 121-132.
    • (2002) Integrative Cancer Therapies , vol.1 , pp. 121-132
    • Giovannucci, E.1    Rimm, E.B.2    Liu, Y.3
  • 333
    • 1342344071 scopus 로고    scopus 로고
    • Tea beverage in chemo prevention of prostate cancer: A mini-review
    • M. Saleem, V. M. Adhami, I. A. Siddiqui, et al., Tea beverage in chemo prevention of prostate cancer: A mini-review, Nutrition and Cancer 47 (2003): 13-23
    • (2003) Nutrition and Cancer , vol.47 , pp. 13-23
    • Saleem, M.1    Adhami, V.M.2    Siddiqui, I.A.3
  • 334
    • 0345256385 scopus 로고    scopus 로고
    • Protective effect of green tea against prostate cancer: A case-control study in southeast china
    • L. Jian, L. P. Xie, A. H. Lee, et al., Protective effect of green tea against prostate cancer: A case-control study in southeast China, International Journal of Cancer 108 (2004): 130-135.
    • (2004) International Journal of Cancer , vol.108 , pp. 130-135
    • Jian, L.1    Xie, L.P.2    Lee, A.H.3
  • 335
    • 85047687822 scopus 로고    scopus 로고
    • Emerging evidence on the role of soy in reducing pros tate cancer risk
    • M. J. Messina, Emerging evidence on the role of soy in reducing pros tate cancer risk, Nutrition Reviews 61 (2003): 117-131
    • (2003) Nutrition Reviews , vol.61 , pp. 117-131
    • Messina, M.J.1
  • 336
    • 1542504193 scopus 로고    scopus 로고
    • Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5 b]pyridine (phip)
    • A. Hikosaka, M. Asamoto, N. Hokaiwado, et al., Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5 b]pyridine (PhIP), Carcinogenesis 25 (2004): 381-387;
    • (2004) Carcinogenesis , vol.25 , pp. 381-387
    • Hikosaka, A.1    Asamoto, M.2    Hokaiwado, N.3
  • 337
    • 11144354162 scopus 로고    scopus 로고
    • A case-control study of diet and prostate cancer in japan: Possible protective effect of traditional japanese diet
    • T. Sonoda, Y. Nagata, M. Mori, et al., A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet, Cancer Science 95 (2004): 238-242.
    • (2004) Cancer Science , vol.95 , pp. 238-242
    • Sonoda, T.1    Nagata, Y.2    Mori, M.3
  • 341
    • 0032542759 scopus 로고    scopus 로고
    • Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
    • O. P. Heinonen, D. Albanes, J. Virtamo, et al., Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial, Journal of the National Cancer Institute 90 (1998): 440-446
    • (1998) Journal of the National Cancer Institute , vol.90 , pp. 440-446
    • Heinonen, O.P.1    Albanes, D.2    Virtamo, J.3
  • 342
    • 0034694665 scopus 로고    scopus 로고
    • Gamma-tocopherol: A new player in pros tate cancer prevention? (editorial)
    • E. Giovannucci, Gamma-tocopherol: A new player in pros tate cancer prevention? (editorial), Journal of the National Cancer Institute 92 (2000): 1966-67
    • (2000) Journal of the National Cancer Institute , vol.92 , pp. 1966-1967
    • Giovannucci, E.1
  • 343
    • 0034694675 scopus 로고    scopus 로고
    • Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer
    • K. J. Helzlsouer, H.-Y. Huang, A. J. Alberg, et al., Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer, Journal of the National Cancer Institute 92 (2000): 2018-23.
    • (2000) Journal of the National Cancer Institute , vol.92 , pp. 2018-2023
    • Helzlsouer, K.J.1    Huang, H.-Y.2    Alberg, A.J.3
  • 345
    • 4744372695 scopus 로고    scopus 로고
    • Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis
    • G. Bjelakovic, D. Nikolova, R. G. Simonetti, et al., Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis, Lancet 364 (2004): 1219-28.
    • (2004) Lancet , vol.364 , pp. 1219-1228
    • Bjelakovic, G.1    Nikolova, D.2    Simonetti, R.G.3
  • 347
    • 20444459516 scopus 로고    scopus 로고
    • Sun exposure, vitamin d receptor gene polymorphisms, and risk of advanced prostate cancer
    • E. M. John, G. G. Schwartz, J. Koo, et al., Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer, Cancer Research 65 (2005): 5470-79.
    • (2005) Cancer Research , vol.65 , pp. 5470-5479
    • John, E.M.1    Schwartz, G.G.2    Koo, J.3
  • 348
    • 0347759930 scopus 로고    scopus 로고
    • The prostate cancer prevention trial: Current status
    • B. Higgins and I. M. Thompson, The prostate cancer prevention trial: Current status, Journal of Urology 171 (2004): S15-S18
    • (2004) Journal of Urology , vol.171
    • Higgins, B.1    Thompson, I.M.2
  • 349
    • 0038340257 scopus 로고    scopus 로고
    • A big study yields big questions
    • A. Zuger, A big study yields big questions, New England Journal of Medicine 349 (2003): 213-214.
    • (2003) New England Journal of Medicine , vol.349 , pp. 213-214
    • Zuger, A.1
  • 351
    • 18744387733 scopus 로고    scopus 로고
    • The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report
    • M. S. Cyrus-David, A. Weinberg, T. Thompson, et al., The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report, Journal of Urology 173 (2005): 1923-25;
    • (2005) Journal of Urology , vol.173 , pp. 1923-1925
    • Cyrus-David, M.S.1    Weinberg, A.2    Thompson, T.3
  • 353
    • 0842308391 scopus 로고    scopus 로고
    • Prostate cancer and use of nonsteroidal anti-inflammatory drugs: Systematic review and meta-analysis
    • S. Mahmud, E. Franco, and A. Aprikian, Prostate cancer and use of nonsteroidal anti-inflammatory drugs: Systematic review and meta-analysis, British Journal of Cancer 90 (2004): 93-99
    • (2004) British Journal of Cancer , vol.90 , pp. 93-99
    • Mahmud, S.1    Franco, E.2    Aprikian, A.3
  • 354
    • 21244487132 scopus 로고    scopus 로고
    • A large cohort study of aspirin and other nonsteroidal antiinflammatory drugs and prostate cancer incidence
    • E. J. Jacobs, C. Rodriguez, A. M. Mondul, et al., A large cohort study of aspirin and other nonsteroidal antiinflammatory drugs and prostate cancer incidence, Journal of the National Cancer Institute 97 (2005): 975-980.
    • (2005) Journal of the National Cancer Institute , vol.97 , pp. 975-980
    • Jacobs, E.J.1    Rodriguez, C.2    Mondul, A.M.3
  • 355
    • 0034807169 scopus 로고    scopus 로고
    • Does physical activity play a role in the prevention of prostate cancer?
    • I.-M. Lee, H. D. Sesso, J.-J. Chen, et al., Does physical activity play a role in the prevention of prostate cancer? Epidemiologic Reviews 23 (2001): 132-137
    • (2001) Epidemiologic Reviews , vol.23 , pp. 132-137
    • Lee, I.-M.1    Sesso, H.D.2    Chen, J.-J.3
  • 356
    • 2342571600 scopus 로고    scopus 로고
    • Case control study of lifetime total physical activity and prostate cancer risk
    • C. M. Friedenreich, S. E. McGregor, K. S. Courneya, et al., Case control study of lifetime total physical activity and prostate cancer risk, American Journal of Epidemiology 159 (2004): 740-749
    • (2004) American Journal of Epidemiology , vol.159 , pp. 740-749
    • Friedenreich, C.M.1    McGregor, S.E.2    Courneya, K.S.3
  • 357
    • 12844285610 scopus 로고    scopus 로고
    • Recreational physical activity and risk of prostate cancer in a large cohort of U.S. Men, cancer epidemiology
    • A. V. Patel, C. Rodriguez, E. J. Jacobs, et al., Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men, Cancer Epidemiology, Biomarkers, and Prevention 14 (2005): 275-279
    • (2005) Biomarkers, and Prevention , vol.14 , pp. 275-279
    • Patel, A.V.1    Rodriguez, C.2    Jacobs, E.J.3
  • 358
    • 18344393348 scopus 로고    scopus 로고
    • A prospective study of physical activity and incident and fatal prostate cancer
    • E. L. Giovannucci, Y. Liu, M. F. Leitzmann, et al., A prospective study of physical activity and incident and fatal prostate cancer, Archives of Internal Medicine 165 (2005): 1005-10.
    • (2005) Archives of Internal Medicine , vol.165 , pp. 1005-1010
    • Giovannucci, E.L.1    Liu, Y.2    Leitzmann, M.F.3
  • 359
    • 17144381637 scopus 로고    scopus 로고
    • Stronger associa tion between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years
    • S. J. Freedland, W. B. Isaacs, L. A. Mangold, et al., Stronger associa tion between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years, Clinical Cancer Research 11 (2005): 2883-88
    • (2005) Clinical Cancer Research , vol.11 , pp. 2883-2888
    • Freedland, S.J.1    Isaacs, W.B.2    Mangold, L.A.3
  • 360
    • 30344476141 scopus 로고    scopus 로고
    • Obesity, serum prostate specific antigen and prostate size
    • S. J. Freedland, E. A. Platz, J. C. Presti, et al., Obesity, serum prostate specific antigen and prostate size, Journal of Urology 175 (2006): 500-4.
    • (2006) Journal of Urology , vol.175 , pp. 500-504
    • Freedland, S.J.1    Platz, E.A.2    Presti, J.C.3
  • 361
    • 13544267779 scopus 로고    scopus 로고
    • Obesity and the risk of prostate cancer
    • M. P. Porter and J. L. Stanford, Obesity and the risk of prostate cancer, Prostate 62 (2005): 316-321.
    • (2005) Prostate , vol.62 , pp. 316-321
    • Porter, M.P.1    Stanford, J.L.2
  • 362
    • 23744506376 scopus 로고    scopus 로고
    • Intensive lifestyle changes may affect the progression of prostate cancer
    • D. Ornish, G. Weidner, W. R. Fair, et al., Intensive lifestyle changes may affect the progression of prostate cancer, Journal of Urology 174 (2005): 1065-70.
    • (2005) Journal of Urology , vol.174 , pp. 1065-1070
    • Ornish, D.1    Weidner, G.2    Fair, W.R.3
  • 363
    • 2342644800 scopus 로고    scopus 로고
    • Why we're losing the war on cancer (and how to win it)
    • March 22
    • C. Leaf, Why we're losing the war on cancer (and how to win it), Fortune, March 22, 2004, 77.
    • (2004) Fortune , pp. 77
    • Leaf, C.1
  • 365
    • 16644403246 scopus 로고    scopus 로고
    • The man who changed medicine
    • November 29
    • C. Daniels, The man who changed medicine, Fortune, November 29, 2004, 90ff.
    • (2004) Fortune , pp. 90
    • Daniels, C.1
  • 366
    • 0002584538 scopus 로고    scopus 로고
    • The man's cancer
    • April 1
    • Leon Jaroff, The man's cancer, Time, April 1, 1996.
    • (1996) Time
    • Jaroff, L.1
  • 367
    • 84902946599 scopus 로고    scopus 로고
    • U.S. Senate adopts resolution encouraging doctors to inform prostate cancer patients about all proven treatments
    • October 13
    • U.S. Senate adopts resolution encouraging doctors to inform prostate cancer patients about all proven treatments, Business Wire, October 13, 2004.
    • (2004) Business Wire
  • 369
    • 0032145984 scopus 로고    scopus 로고
    • Screening digital rectal examination and prostate cancer mortality: A population-based case control study
    • S. J. Jacobsen, E. J. Bergstralh, S. K. Katusic, et al., Screening digital rectal examination and prostate cancer mortality: A population-based case control study, Urology 52 (1998): 173-179;
    • (1998) Urology , vol.52 , pp. 173-179
    • Jacobsen, S.J.1    Bergstralh, E.J.2    Katusic, S.K.3
  • 370
    • 1842430177 scopus 로고    scopus 로고
    • Prostate cancer screening and mortality: A case-control study (United States)
    • S. J. Jacobsen, E. J. Bergstralh, S. K. Katusic, et al., Prostate cancer screening and mortality: A case-control study (United States), Cancer Causes and Control 14 (2004): 133-138.
    • (2004) Cancer Causes and Control , vol.14 , pp. 133-138
    • Jacobsen, S.J.1    Bergstralh, E.J.2    Katusic, S.K.3
  • 371
    • 0034860041 scopus 로고    scopus 로고
    • Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the federal state of Tyrol, Austria
    • G. Bartsch, W. Horninger, H. Klocker, et al., Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria, Urology 58 (2001): 417-424.
    • (2001) Urology , vol.58 , pp. 417-424
    • Bartsch, G.1    Horninger, W.2    Klocker, H.3
  • 374
    • 0034572611 scopus 로고    scopus 로고
    • The prostate, lung, colo rectal and ovarian (plco) cancer screening trial of the national cancer institute: History, organization, status
    • J. K. Gohagan, P. C. Prorok, R. B. Hayes, et al., The Prostate, Lung, Colo rectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, status, Controlled Clinical Trials 21 (2000): 251S-272S
    • (2000) Controlled Clinical Trials , vol.21
    • Gohagan, J.K.1    Prorok, P.C.2    Hayes, R.B.3
  • 375
    • 0031403880 scopus 로고    scopus 로고
    • The european randomized study of screening for prostate cancer (erspc)
    • F. H. Schröder and C. H. Bangma, The European Randomized Study of Screening for Prostate Cancer (ERSPC), British Journal of Urology 79 (suppl. 1) (1997): 68-71.
    • (1997) British Journal of Urology , vol.79 , Issue.SUPPL. 1 , pp. 68-71
    • Schröder, F.H.1    Bangma, C.H.2
  • 376
    • 4544254807 scopus 로고    scopus 로고
    • The prostate specific antigen era in the united states is over for prostate cancer: What happened in the last 20 years?
    • T. A. Stamey, M. Caldwell, J. E. McNeal, et al., The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? Journal of Urology 172 (2004): 1297-1301.
    • (2004) Journal of Urology , vol.172 , pp. 1297-1301
    • Stamey, T.A.1    Caldwell, M.2    McNeal, J.E.3
  • 377
    • 24644458921 scopus 로고    scopus 로고
    • The psa era is not over for prostate cancer
    • W. J. Catalona and S. Loeb, The PSA era is not over for prostate cancer, European Urology 48 (2005): 541-545.
    • (2005) European Urology , vol.48 , pp. 541-545
    • Catalona, W.J.1    Loeb, S.2
  • 379
    • 0034875454 scopus 로고    scopus 로고
    • Low levels of prostate-specific antigen predict long-term risk of prostate cancer: Results from the baltimore longitudinal study of aging
    • J. Fang, E. J. Metter, P. Landis, et al., Low levels of prostate-specific antigen predict long-term risk of prostate cancer: Results from the Baltimore Longitudinal Study of Aging, Urology 58 (2001): 411-416;
    • (2001) Urology , vol.58 , pp. 411-416
    • Fang, J.1    Metter, E.J.2    Landis, P.3
  • 380
    • 0028801975 scopus 로고
    • A prospective evaluation of plasma prostatespecific antigen for detection of prostatic cancer
    • P. H. Gann, C. H. Hennekens, and M. J. Stampfer, A prospective evaluation of plasma prostatespecific antigen for detection of prostatic cancer, Journal of the American Medical Association 273 (1995): 289-294.
    • (1995) Journal of the American Medical Association , vol.273 , pp. 289-294
    • Gann, P.H.1    Hennekens, C.H.2    Stampfer, M.J.3
  • 381
    • 23744512048 scopus 로고    scopus 로고
    • Prostate specific antigen levels in young adulthood predict prostate cancer risk: Results from a cohort of black and white Americans
    • A. S. Whittemore, P. M. Cirillo, D. Feldman, et al., Prostate specific antigen levels in young adulthood predict prostate cancer risk: Results from a cohort of black and white Americans, Journal of Urology 174 (2005): 872-876.
    • (2005) Journal of Urology , vol.174 , pp. 872-876
    • Whittemore, A.S.1    Cirillo, P.M.2    Feldman, D.3
  • 383
    • 1842862680 scopus 로고    scopus 로고
    • Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer
    • C. Kumar-Sinha and A. M. Chinnaiyan, Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer, Urology 62 (suppl. 6B) (2003): 19-35.
    • (2003) Urology , vol.62 , Issue.SUPPL. 6B , pp. 19-35
    • Kumar-Sinha, C.1    Chinnaiyan, A.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.